technetium tc 99m sestamibi has been researched along with Breast Cancer in 458 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 173 (37.77) | 18.2507 |
2000's | 204 (44.54) | 29.6817 |
2010's | 72 (15.72) | 24.3611 |
2020's | 9 (1.97) | 2.80 |
Authors | Studies |
---|---|
Huic, D; Jozanovic, V | 1 |
Hruska, CB | 1 |
Hatcher, KM; Maimone, S; Robinson, KA; Tavana, A | 1 |
Kappadath, SC; Lopez, BP | 1 |
Benard, M; Corion, CLS; de Geus-Oei, LF; Pereira Arias-Bouda, LM; Smithuis, RHM; Valdés Olmos, RA; van der Hage, JA; van Loevezijn, AA; Wijers, LMH; Zeillemaker, AM | 1 |
Duvall, WL; Henzlova, MJ | 1 |
Anello, MI; Bandos, AI; Berg, WA; Carter, GJ; Chough, DM; Ganott, MA; Gur, D; Hakim, CM; Houshmand, G; Kelly, AE; Sumkin, JH; Zuley, ML | 1 |
Bonanno, E; Schillaci, O; Scimeca, M; Tancredi, V; Urbano, N | 1 |
Liu, H; Sun, D; Zhan, H | 1 |
Jain, R; Kapoor, AD; Katz, DR | 1 |
Arias-Bouda, LMP; Collarino, A; de Geus-Oei, LF; den Hartog, WC; Neijenhuis, PA; Olmos, RAV; Smit, F | 1 |
Choi, YY; Chung, MS; Kim, C; Lee, SJ | 1 |
Collarino, A; de Geus-Oei, LF; de Koster, EJ; Pereira Arias-Bouda, LM; Valdés Olmos, RA | 1 |
Brem, RF; Huppe, AI; Mehta, AK | 1 |
Kim, BS; Yoo, J; Yoon, HJ | 1 |
Collarino, A; de Geus-Oei, LF; Dibbets-Schneider, P; Pereira Arias-Bouda, LM; Valdés Olmos, RA; van der Tol, P; van Velden, FHP | 1 |
Choi, EK; Chung, YA; Im, JJ; Kim, K; Oh, JK; Park, CS | 1 |
Abedi, SM; Behzadi, R; Ghasmi, M; Hallajian, F; Hayati, E; Karimi, H; Rezazadeh, F; Sadeghzadeh, N | 1 |
Gross, MD; Singh, H; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
Conners, AL; Hruska, CB; Hunt, KN; O'Connor, MK; Rhodes, DJ; Solberg, CM; Swanson, TN; Tran, TD | 1 |
Chernaya, AV; Kanaev, SV; Klitcenko, OA; Krivorotko, PV; Krzhivitskii, PI; Novikov, SN; Popova, NS | 1 |
Bonanno, E; Schillaci, O; Scimeca, M; Urbano, N | 1 |
Chaudhuri, D; Cunningham, T; Hoang, K; Hoefer, R; Kelley, A; Kim, S; Plemmons, J | 1 |
Brandt, KR; Conners, AL; Degnim, AC; Geske, JR; Hruska, CB; Hunt, KN; O'Connor, MK; Rhodes, DJ; Vachon, CM | 1 |
Aspitia, AM; Boughey, JC; Carter, J; Conners, AL; Goetz, MP; Gray, R; Hunt, KN; Kalari, K; McLaughlin, S; Northfelt, D; O'Connor, MK; Suman, V; Wang, L; Weinshilboum, R | 1 |
Deng, Z; Dong, A; Liu, Y; Tang, Y; Zhao, M | 1 |
Kanaev, SV; Krivorot'ko, PV; Kryzhevitskiĭ, PI; Novikov, SN; Semiglazov, VF; Semiglazova, TIu; Zhukova, LA; Zotova, OV | 1 |
Kanaev, SV; Krivorot'ko, PV; Kryzhevitskiĭ, PI; Negustorov, IuF; Novikov, SN; Semënov, II; Semiglazov, VF; Semiglazova, TIu; Zhukova, LA | 1 |
Krivorot'ko, PV | 1 |
Cha, ES; Kim, JS; Lee, SM | 1 |
Gu, Y; Han, L; Jiang, L; Shi, H; Tan, H; Wu, P; Xiu, Y; Zhang, H | 1 |
Boughey, JC; Conners, AL; Hruska, CB; Jones, KN; Mitchell, D; O'Connor, MK; Tortorelli, C; Wahner-Roedler, DL | 1 |
Danieli, R; Madeddu, G; Schillaci, O; Spanu, A | 1 |
Kim, BS; Moon, BI; Sung, SH; Yoon, HJ | 1 |
Brem, RF; Lenihan, MJ; Lieberman, JH; Rapelyea, JA; Rechtman, LR; Teal, CB; Torrente, J | 1 |
Abeyakoon, O; Baltzer, P; Bickel, H; Brader, P; Füger, B; Helbich, T; Magometschnigg, HF; Pinker, K; Polanec, S; Wengert, G | 1 |
Aryana, K; Ayati, N; Azarian, A; Fattahi, A; Forghani, MN; Sadeghi, R; Sadri, K; Shariati, F; Zakavi, SR | 1 |
Bennetts, L; Blanchard, D; Bryn, S; Garreau, J; Glissmeyer, M; Johnson, N; Johnson, W; Sorenson, L; Winter, K | 1 |
Jeon, YK; Kim, BH; Kim, IJ; Kim, SJ; Kim, SS; Kim, YK; Lee, SH | 1 |
Bignotto, M; Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Michieletto, S; Paiusco, M; Saibene, T; Saladini, G; Sanco, R | 1 |
Doležal, J; Doležel, M; Hyšpler, R; Kalábová, H; Krčmová, LK; Melichar, B; Pecen, L; Pecka, M; Solichová, D; Srámek, V; Studentová, H; Svobodník, A; Vošmik, M | 1 |
Kim, BS; Kim, Y; Lee, JE; Yoon, HJ | 1 |
Ilin, ND; Jukova, LA; Kanaev, SV; Krivorotko, PV; Krzhivitskii, PI; Novikov, SN; Ponomareva, OI | 1 |
Bozza, F; Cervino, AR; Evangelista, L; Ghiotto, C; Michieletto, S; Orvieto, E; Saibene, T | 1 |
Hergan, K; Holzmannhofer, J; Keinrath, P; Meissnitzer, MW; Meissnitzer, T; Pirich, C; Seymer, A | 1 |
Boughey, JC; Conners, AL; Hruska, CB; Jones, KN; Moriarty, JP; O'Connor, MK; Rhodes, DJ | 1 |
Elena, TA; Kanaev, SV; Ludmila, JA; Nikolay, ID; Novikov, SN; Pavel, KI; Petr, KV; Tatyana, SY; Zhanna, BV | 1 |
Gong, Z; Williams, MB | 1 |
Boughey, JC; Conners, AL; Geske, JR; Hruska, CB; Jones, KN; Rhodes, DJ | 1 |
Neijenhuis, PA; Pereira Arias-Bouda, LM; van Breda Vriesman, AC; van Loevezijn, AA | 1 |
Guo, C; Huang, G; Liu, J; Tong, L; Zhang, C | 1 |
Green, VL | 1 |
Cheng, D; Du, M; Fu, Y; Gu, Y; Shi, H; Tan, H; Yang, W; Zhang, H | 1 |
Hong, AS; Jaeger, BM; Letter, H; Odell, MC | 1 |
Brenner, RJ; Doyle, MT; Kudrolli, H; Martin, TS; Merryman, D; Shermis, RB; Wilson, KD | 1 |
Even-Sapir, E; Golan, O; Lerman, H; Menes, T; Weinstein, Y | 1 |
Hendrick, RE; Tredennick, T | 1 |
Chen, Y; Deng, Y; Hu, G; Huang, J; Qiu, F; Shao, X; Wang, X; Yu, X; Zhan, H; Zhang, Z | 1 |
Ammar, KA; Anigbogu, M; Port, SC; Shaikh, A | 1 |
Abu al Huda, F; al Mohannadi, S; Javed, A; Kamal, S; Khan, HA; Niaz, K; Niyaz, K; Usmani, S; Uz-Zaman, M | 1 |
Boughey, JC; Degnim, AC; Hruska, CB; O'Connor, MK; Phillips, SW; Rhodes, DJ; Wahner-Roedler, DL; Whaley, DH | 1 |
Kim, IJ; Kim, SJ; Kim, YK | 2 |
Hruska, CB; O'Connor, MK; Phillips, SW; Rhodes, DJ; Whaley, DH | 2 |
Buckle, T; Gilhuijs, KG; Kersbergen, A; Rottenberg, S; van Leeuwen, FW | 1 |
Bertrand, ML; Brem, RF; Ioffe, M; Rapelyea, JA; Stern, LH; Weigert, JM; Yost, KG | 1 |
Bryn, S; Ecklund, GW; Glissmeyer, M; Gruner, S; Johnson, N; Meunier, P; Steinbock, K; Zhou, M | 1 |
Fatima, N; Hashmi, A; Hashmi, H; Nasir, Z; Raza, T; Zaman, MU | 1 |
Borsato, S; Bui, F; Cecchin, D; Fassina, A; Ferretti, G; Lumachi, F; Marzola, MC; Povolato, M; Tregnaghi, A; Zucchetta, P | 1 |
Brem, RF; Floerke, AC; Rapelyea, JM; Riordan, W | 1 |
Abufalgha, K; Al-Nahhas, A; Grassetto, G; Grosso, M; Imran, MB; Mariani, G; Roncella, M; Rubello, D; Volterrani, D | 1 |
Hruska, C; O'Connor, M; Rhodes, D | 1 |
Habib, S; Hameed, A; Hashmi, H; Kamal, S; Niaz, K | 1 |
Bianchi, F; Chiacchio, S; Cilotti, A; Grosso, M; Manca, G; Mariani, G; Marini, C; Marzola, MC; Rampin, L; Roncella, M; Rubello, D; Traino, C; Volterrani, D | 1 |
Hardy, M; Kalyanaraman, B; Li, Z; Lopez, M; McAllister, DM; Zhao, M | 1 |
Blanchard, DA; Jones, EA; Miley, A; Phan, TD | 1 |
Bach, AD; Dragu, A; Horch, RE; Kneser, U; Kuwert, T; Linke, R; Stürzl, M; Unglaub, F | 1 |
Al Huda, FA; Al Mohannadi, S; Al Shammary, I; Javed, A; Khan, HA; Usmani, S | 1 |
Gunn, S; Judy, PG; Majewski, S; Williams, MB | 1 |
Tunio, MA | 1 |
Ahmed, N; Garvie, N; Khan, H; Marafi, F; Usmani, S | 1 |
Aryana, K; Ayati, NK; Forghani, MN; Ghavamnasiri, MR; Kakhki, VR; Keshtgar, M; Sadeghi, R; Shandiz, FH; Zakavi, SR | 1 |
Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Lu, ZD; Yang, H; Zhang, HW | 2 |
Gupta, MK; Mardi, K; Seam, RK; Sethi, S; Sood, A | 1 |
Boolbol, SK; Cohen, I; Fulop, T; Keto, JL; Kirstein, L; McPartland, L; Sanchez, DP | 1 |
Jacobsson, H | 1 |
Li, L; Xu, HB; Xu, Q | 1 |
Bonomi, M; Crescentini, G; Crocetti, A; de Cesare, A; De Vincentis, G; DeCesare, A; Enrico, F; Fiori, E; Gervasi, S; Giacomo, C; Giuseppe, de V; Marco, B; Stefano, G; Sterpetti, AV | 1 |
Kim, BS | 1 |
Al-Saeedi, FJ; Bitar, M; Pariyani, S | 1 |
Bertrand, ML; Kieper, DA; Lanzkowsky, L; Stern, LH; Weigert, JM | 1 |
Kanaev, CV; Krivorot'ko, PV; Krzhivitskiĭ, PI; Novikov, SN; Semiglazov, VF; Zhukova, LA | 1 |
Deng, S; Wan, W; Wu, Y; Yen, TC; Yu, C; Zhang, B | 1 |
Askew, JW; Collins, DA; Hruska, CB; O'Connor, MK; Rhodes, DJ; Tortorelli, CL | 1 |
Li, X; Si, H | 1 |
Birkenfeld, B; Foszczyńska-Kłoda, M; Listewnik, MH; Listewnik, MJ; Piwowarska-Bilska, H; Zorga, P | 1 |
Becker, I; Brinkbäumer, K; Hahn, K; Kessler, M; Linke, R; Sommer, H; Tiling, R; Untch, M | 1 |
Leung, JW | 1 |
Alonso, O; Andruskevicius, P; Delgado, L; Gaudiano, J; Lopera, J; Musé, IM; Núñez, M; Roca, R; Sabini, G; Vargas, C | 1 |
Archimandritis, SC; Datsteris, J; De Vincentis, G; Evangelatos, GP; Scopinaro, F; Sourlingas, TG; Ussof, W; Varvarigou, AD | 1 |
Hirai, T; Kim, R; Osaki, A; Toge, T | 1 |
Ahn, SJ; Chung, JK; Chung, KW; Im, JG; Kim, SW; Moon, WK; Noh, DY; Park, SS; Yeo, JS | 1 |
Kasner, DL; Spieth, ME | 1 |
Chan, T; Chen, YS; Kao, A; Sun, SS; Wang, WH | 1 |
Jin, S; Liang, C; Ren, C; Wang, H; Zhou, Q; Zhu, H | 1 |
Charlop, AW; Dunnwald, LK; Ellis, GK; Gralow, JR; Livingston, RB; Mankoff, DA; Rinn, KJ; Schubert, EK; Tseng, J | 1 |
Brandes, AA; Bui, F; Ferretti, G; Lumachi, F; Marzola, MC; Paris, MK; Povolato, M; Zucchetta, P | 1 |
Biersack, HJ; Hensel, J; Matthies, A; Palmedo, H; Reinhardt, M; Von Mallek, D | 1 |
Khalkhali, I; Romero, L; Vargas, HI | 1 |
Belhaj-Tayeb, H; Bendada, SE; Briane, D; Cao, A; Kothan, S; Léger, G; Moretti, JL; Tamgac, F; Tofighi, M; Vergote, J | 1 |
Bomanji, JB; Chande, H; Maunda, KY; Mselle, TF | 1 |
Chessa, F; Falchi, A; Farris, A; Madeddu, G; Nuvoli, S; Schillaci, O; Solinas, ME; Spanu, A | 1 |
De Bree, E; Kafousi, M; Karkavitsas, N; Kodogiannis, E; Koukouraki, S; Manios, A; Sanidas, EE; Stathopoulos, E; Tsiftsis, DD; Velidaki, A | 1 |
Aspelin, P; Boné, B; Danielsson, R; Grabowska, H; Larsson, SA; Pegerfalk, A; Sánchez-Crespo, A | 1 |
Brinkbäumer, K; Hahn, K; Kessler, M; Linke, R; Sommer, H; Tiling, R; Untch, M | 1 |
Boné, B; Danielsson, R; Szabó, BK; Szakos, A; Wiberg, MK | 1 |
Conrad, GR; Sinha, P; Sloan, DA | 1 |
Aloj, L; Del Vecchio, S; Salvatore, M; Zannetti, A | 1 |
Fuster, D; Mallafré, C; Martín, F; Pavia, J; Pons, F; Viñolas, N | 1 |
Aloj, L; Caracò, C; Ciarmiello, A; Del Vecchio, S; Salvatore, M; Zannetti, A | 1 |
Capoccetti, F; Mezi, S; Modesti, M; Primi, F; Schillaci, O; Scopinaro, F | 1 |
Bergh, J; Eriksson, E; Jacobsson, H; Larsson, SA; von Schoultz, E; Wilczek, B | 2 |
Aspelin, P; Boné, B; Danielsson, R; Frisell, J; Pegerfalk, A; Wilczek, B | 1 |
Anga, B; Bódis, J; Kett, K; Schmidt, E; Zámbó, K | 1 |
Denis, R; Fleiszer, D; Martin, G; Nassif, E; Picard, D; Sampalis, FS; Sampalis, JS | 2 |
Chen, J; Hu, J; Wu, H; Zhou, J | 1 |
Bagni, B; Bagni, I; Casolo, A; De Santis, M; Di Leo, C; Franceschetto, A; Pansini, F | 1 |
Buscombe, JR; Cwikła, JB; Hilson, AJ; Holloway, B; Kolasińska, AD | 1 |
Aras, T; Arslan, N; Aşan, E; Gürcan, N; Korkusuz, P; Sari, O; Sökmensüer, C; Uğur, O; Uğur, Y; Varoğlu, E; Yildirim, M | 1 |
Chang, HT; Liu, RS; Peng, NJ; Tsay, DG | 1 |
Hod, N; Horne, T; Mindlin, L | 1 |
Bunko, H; Kinuya, S; Li, XF; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
Denoyer, D; Dubois, F; Frère, D; Le Jeune, N; Perek, N | 1 |
Aloj, L; Caracó, C; Del Vecchio, S; Salvatore, M; Zannetti, A | 1 |
Fleming, RM | 1 |
Balci, P; Bekiş, R; Canda, T; Değirmenci, B; Derebek, E; Durak, H; Koçdor, MA | 1 |
Ambela, C; Christodoulidou, JK; Koutsikos, J; Lazaris, D; Louvrou, AN; Melissinou, MJ; Papantoniou, VJ; Perperoglou, A; Sotiropoulou, MG; Souvatzoglou, MA; Tsiouris, S; Valotassiou, VJ; Zerva, CJ | 1 |
Aktolun, C; Baum, RP; Bishof-Delaloye, A; Bombardieri, E; Buscombe, J; Chatal, JF; Maffioli, L; Moncayo, R; Mortelmans, L; Reske, SN | 1 |
Bae, YT; Kim, DS; Kim, IJ; Kim, SJ; Kim, YK | 3 |
Madeddu, G; Spanu, A | 1 |
Buscombe, JR; Schillaci, O | 1 |
Del Vecchio, S; Salvatore, M | 2 |
Wu, H; Zhang, X; Zhang, Z; Zhao, M | 1 |
Scheidhauer, K; Seemann, MD; Walter, C | 1 |
Barrett, HH; Bettan, M; Furenlid, LR; Kastis, GA; Liu, Z; Pak, KY; Stevenson, GD; Wilson, DW; Woolfenden, JM | 1 |
Wu, H; Zhang, XM; Zhang, ZW | 1 |
Anglade, E; Berger, V; Fauvet, R; Fondrinier, E; Jallet, P; Lorimier, G; Muratet, JP | 1 |
Koutsikos, J; Lazaris, D; Mainta, E; Papantoniou, V; Sotiropoulou, M; Tsiouris, S; Zerva, C | 1 |
Chaudhary, KS; Harrington, KJ; Lalani, el-N; Mubashar, M; Peters, AM; Stamp, GW | 1 |
Hahn, K; Linke, R; Shabani, N; Sommer, H; Stephan, K; Tiling, R | 1 |
Cachin, F; Cayre, A; Maublant, J; Mestas, D; Penault-Llorca, F | 1 |
Celebiouglu, F; Danielsson, R; Jacobsson, H; Larsson, SA; Svensson, L; Wilczek, B | 1 |
El-Sheemy, M; Eremin, J; Eremin, O; Griffiths, PA; Marshall, C | 1 |
Barlow, WE; Dunnwald, LK; Ellis, GK; Gralow, JR; Lawton, TJ; Linden, HM; Livingston, RB; Mankoff, DA; Schubert, EK | 1 |
Koutsikos, J; Lazaris, D; Louvrou, A; Mainta, E; Melissinou, M; Nakopoulou, L; Papantoniou, V; Pirmettis, I; Sotiropoulou, M; Souvatzoglou, M; Tsiouris, S; Tzannetaki, A; Valotassiou, V; Zerva, C | 1 |
Batista, JF; Bush, ML; Coca, MA; Peña, Y; Perera, A; Sánchez, EL | 1 |
Baio, S; Cassano, E; De Cicco, C; Galimberti, V; Gatti, G; Luini, A; Paganelli, G; Pizzamiglio, M; Prisco, G; Sierra, ML; Trifirò, G | 1 |
Hahn, K; Kessler, M; Linke, R; Sommer, H; Tiling, R; Untch, M | 1 |
Collins, DA; O'Connor, MK; Phillips, SW; Rhodes, DJ; Smith, RL | 1 |
Taillefer, R | 2 |
Aras, G; Arcan, P; Cam, R; Ibis, E; Küçük, NO | 1 |
Griffiths, PA; Marshall, C | 1 |
Kim, MW; Lee, NR; Lim, ST; Sohn, MH; Song, EK; Yim, CY | 1 |
Cwiertka, K; Dusková, M; Hartlová, M; Husák, V; Kamínek, M; Koranda, P; Myslivecek, M | 1 |
Aydin, A; Bekiş, R; Canda, T; Degirmenci, B; Durak, H; Ozdogan, O | 1 |
Basso, SM; Brandes, AA; Bui, F; Cecchin, D; Ermani, M; Lumachi, F; Marzola, MC; Zucchetta, P | 1 |
Blumenschein, G; Boniface, G; Booser, D; Fleming, DR; Hortobagyi, GN; Ibrahim, N; Pusztai, L; Rivera, E; Rouzier, R; Symmans, FW; Theriault, R; Wagner, P; Wong, F | 1 |
Booker, J; Clark, D; Howarth, D; Lau, P; Sillar, R; Slater, S | 1 |
Barrett, HH; Bettan, M; Furenlid, LR; Kastis, GA; Liu, Z; Stevenson, GD; Wilson, DW; Woolfenden, JM | 1 |
Brem, RF; Majewski, S; Mohtashemi, K; Rapelyea, JA; Raub, J; Teal, CB; Welch, BL; Zisman, G | 1 |
Anga, B; Bódis, J; Koppán, M; Schmidt, E; Zámbó, K | 1 |
Destine, M; Lonneux, M; Mathieu, I; Mazy, G; Mazy, S; Willemart, B | 1 |
Baena-Cañada, JM; Benítez, E; García-Curiel, A; Palomo-González, MJ; Partida-Palma, F; Rueda-Ramos, A | 1 |
Cui, SD; Li, LF; Li, WL; Liu, H; Liu, ZZ; Yang, H | 1 |
Brem, RF; Civelek, AC; Ozalp, E; Patel, P | 1 |
Bai, J; Fukuoka, M; Kinuya, S; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
Papantoniou, V; Ptohis, N; Tsiouris, S | 1 |
Canteras, M; Durán, I; Galindo, PJ; Hernández, MD; Illana, J; Nicolás, F; Parrilla, P; Piñero, A; Reus, M | 1 |
Bui, F; Cecchin, D; Ferretti, G; Lumachi, F; Marzola, MC; Povolato, M; Tregnaghi, A; Zucchetta, P | 1 |
Antsaklis, A; Koutsikos, J; Lazaris, D; Mainta, E; Melissinou, M; Papantoniou, V; Sotiropoulou, M; Tsiouris, S; Valsamaki, P; Zerva, C | 1 |
De Vincentis, G; Filippi, L; Masci, E; Pulcini, A; Redler, A; Remediani, S; Scopinaro, F | 1 |
Boer, RO; de Waard, JW; Gommans, GM; Teule, GJ; van der Zant, FM; van Dongen, A | 1 |
Bae, YT; Kim, DS; Kim, IJ; Kim, SJ; Kim, YK; Lee, JS | 1 |
Baio, SM; Colleoni, MA; Cremonesi, M; De Cicco, C; Ferrari, M; Paganelli, G; Prisco, G; Radice, D; Sivolapenko, GB; Travaini, LL; Trifirò, G; Viale, G | 1 |
Kołodziejczyk, A; Patrzyk, R; Piwkowski, P; Zawisza, R; Zebrowski, J; Zielińska, D | 1 |
Anurova, OA; Laktionov, KP; Odzharova, AA; Portnoĭ, SM; Riabchikov, DA; Shiriaev, SV | 1 |
Habib, S; Hashmi, A; Hashmi, H; Kamal, S; Mehboob, J; Niaz, K; Niyaz, K; Usmani, S | 1 |
Alvarenga, M; Bianchessi, ST; Cabello, C; Camargo, EE; Caserta, N; de Lima, MC; Duarte, GM; Etchebehere, EC; Segala, SR; Telles, GH; Torresan, RZ | 1 |
Bae, YT; Kim, IJ; Kim, SJ; Kim, YK; Lee, JS | 1 |
Alvarenga, M; Bianchessi, ST; Cabello, C; Camargo, EE; Caserta, N; de Lima, Mda C; Duarte, GM; Etchebehere, EC; Segala, SR; Telles, GH; Tinois, E; Torresan, RZ | 1 |
Brem, RF; Fishman, M; Rapelyea, JA | 1 |
Kovacević, P; Matavulj, A; Ponorac, N; Rajkovaca, Z; Vuleta, G | 1 |
Habib, S; Kamal, S; Khan, HA; Niaz, K; Niyaz, K; Usmani, S | 1 |
Hao, RR; Li, CL; Yang, JG; Zou, LF | 1 |
Blanchard, D; Bryn, S; Johnson, N; Nelson, J; Zhou, M | 1 |
Brem, RF; Floerke, AC; Kelly, T; Mathur, V; Rapelyea, JA; Teal, C | 1 |
Banci, M; Centi Colella, A; Danieli, R; Di Macio, L; Limiti, MR; Mingazzini, PL; Scarpini, M; Schillaci, O; Scopinaro, F; Zerilli, M | 1 |
Cutrone, JA; Diggles, L; Khalkhali, I; Korbin, CD; Mena, I | 1 |
Bourgeois, P | 1 |
Lambert, R; Laperrière, J; Robidoux, A; Taillefer, R; Turpin, S | 1 |
Cutrone, J; Diggles, L; Jackson, B; Khalkhali, I; Klein, S; Mena, I; Vargas, H; Venegas, R | 1 |
Behrman, RH | 1 |
Aktolun, C | 4 |
Ell, PJ | 1 |
Cutrone, JA; Diggles, LE; Jackson, BL; Khalkhali, I; Khalkhali, S; Klein, SR; Mena, IG; Moss, JF; Vargas, HI; Venegas, RJ | 1 |
Alavi, A; Buchpiguel, C; Chin, BB; Zukerberg, BW | 1 |
Au, FC; Caroline, DF; Jadali, FJ; Maier, WP; Manzone, TA; Maurer, AH; Schnall, SF | 1 |
Chou, C; Huang, HY; Liu, YH; Long, MQ; Lu, G; Shih, WJ; Sun, Q | 1 |
Kao, CH; Wang, SJ; Yeh, SH | 1 |
Kotz, D | 1 |
Bombardieri, E; Capri, G; Castellani, M; Chiti, A; Gasparini, M; Maffioli, L | 1 |
Argon, M; Balkan, Z; Burak, Z; Duman, Y; Erdem, S; Erhan, Y; Memiş, A; Ozkiliç, H; Ustün, EE | 1 |
Diggles, L; Khalkhali, I; Mena, I | 1 |
Kao, CH; Liu, TJ; Wang, SJ | 1 |
Alle, K; Block, J; Diggles, L; Jouanne, E; Khalkhali, I; Klein, S; Mena, I; Venegas, R | 1 |
Costa, M; Moura, L | 1 |
Kandula, P; Shirazi, P | 1 |
Blanchot, C; Caglar, M; Cordobes, MD; Delmon-Moingeon, L; Kouyoumdjian, JC; Moretti, JL; Prévost, G; Starzec, A | 1 |
Charrier, S; Clemenson, A; Dauplat, J; de Latour, M; Feillel, V; Kaufmann, P; Le Bouedec, G; Maublant, J; Mestas, D; Veyre, A | 1 |
Ali, SA; Briscoe, E; Cesani, F; Cowan, D; Hove, M; Leonard, MH; Rhoden, S; Villanueva-Meyer, J | 1 |
Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Schomburg, A | 1 |
Broglia, L; Danieli, R; Narilli, P; Occhiato, R; Passariello, R; Pavone, P; Schillaci, O; Scopinaro, F | 1 |
Park, CH; Park, HB; Whang, HS | 1 |
Chan, YL; King, W; Lam, WW; Metreweli, C; Stewart, IE; Yang, WT | 2 |
Akansel, G; Collier, D; Griffith, O; Hayward, M; Hellman, R; Isitman, AT; Kabasakal, L; Ozker, K | 1 |
Hahn, K | 1 |
Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Schomburg, A | 1 |
Azaloux, H; Boisseron, D; Kouyoumdjian, JC; Moretti, JL; Vilcoq, J | 1 |
Bakker, WH; Benjamins, H; Bernard, BF; Breeman, WA; de Jong, M; Ensing, G; Krenning, EP; Visser, TJ | 2 |
Ficaro, EP; Raylman, RR; Wahl, RL | 1 |
Ballinger, JR; Bannerman, J; Boxen, I; Firby, P; Hartman, NG; Moore, MJ | 1 |
Caindec-Ranchez, S; Davis, J; Wasnich, R; Yuen-Green, M | 1 |
Farnebo, LO; Fernström, A; Jacobsson, H; Jonsson, C | 1 |
Edell, SL | 1 |
Wahl, RL | 1 |
Gordon, B; Gordon, L | 1 |
Biersack, HJ; Boldt, I; Grünwald, F; Mallmann, P; Palmedo, H; Schomburg, A | 1 |
Clifford, EJ; Lugo-Zamudio, C | 1 |
Fukumitsu, N; Kawakami, K; Mori, Y; Tozaki, M; Uchida, K; Uchiyama, M | 1 |
Krenning, EP; Kvols, LK; Van Eijck, CH | 1 |
Androulakis, E; Damilakis, J; Giatromanolaki, A; Karkavitsas, N; Koukouraki, S; Koukourakis, M | 1 |
Diggles, L; Khalkhali, IJ | 1 |
Hahn, K; Kress, K; Moser, R; Pechmann, M; Pfluger, T; Sommer, H; Tatsch, K; Tiling, R | 1 |
Kawasaki, Y; Nishiyama, Y; Ohkawa, M; Satoh, K; Takashima, H; Tanabe, M; Yamamoto, Y | 1 |
Becherer, A; Gnant, M; Helbich, TH; Kelkar, P; Leitha, T; Mostbeck, GH; Rudas, M; Seifert, M; Staudenherz, A; Trattnig, S; Wolf, G | 1 |
Agresti, R; Bombardieri, E; Chiti, A; Crippa, F; Greco, M; Maffioli, LS; Pilotti, S; Savelli, G; Tomasic, G | 1 |
Botti, G; Carriero, MV; Cerra, M; Ciarmiello, A; D'Aiuto, G; Mainolfi, C; Potena, MI; Salvatore, M; Thomas, R; Tsuruo, T; Vecchio, SD | 1 |
Buscombe, JR; Croasdale, IR; Hilson, AJ | 1 |
Assemi, C; Hahn, K; Kindermann, G; Kress, K; Moser, R; Pechmann, M; Pfluger, T; Sommer, H; Tatsch, K; Tiling, R | 1 |
Maublant, J | 1 |
Dobkin, J; Fracasso, PM; Luker, GD; Piwnica-Worms, D | 1 |
Awane, H; Irie, K; Kitai, T; Komibuchi, T; Nishio, T; Ohta, H; Shintaku, M; Ukikusa, M; Yamamoto, S | 1 |
Becherer, A; Helbich, TH; Kelkar, PS; Lehner, R; Mostbeck, GH; Rudas, M | 1 |
Khaw, BA; Nakazawa, A; Narula, J; Pak, KY; Petrov, AD | 1 |
Hall, FM | 1 |
Waxman, AD | 2 |
Carlens, P; Fornander, T; Glas, U; Gyenes, G; Rutqvist, LE | 1 |
de Hooge, P; Perre, CI; Rütter, JE; Vos, PA | 1 |
Baltalï, E; Bekdik, CF; Elahi, N; Hayran, M; Kïratlï, P; Kostakoglu, L; Ruacan, S; Sayek, I; Sungur, A | 1 |
Cutrone, JA; Diggles, LE; Iraniha, S; Khalkhali, I; Klein, SR | 1 |
Değirmenci, B; Derebek, E; Durak, H | 1 |
Clark, D; Howarth, D; Sillar, R | 1 |
Dunnwald, LK; Hartnett, SD; Mankoff, DA | 1 |
Awane, H; Irie, K; Ohta, H; Shintaku, M; Ukikusa, M; Yamamoto, S | 1 |
Cutrone, JA; Diggles, LE; Iraniha, S; Khalkhali, I; Mishkin, FS | 1 |
Lin, X | 1 |
Bender, H; Biersack, HJ; Grünwald, F; Krebs, D; Mallmann, P; Palmedo, H; Zamora, P | 1 |
Barlow, RV; Buscombe, JR; Crow, J; Cwikla, JB; Deery, A; Hilson, AJ; Jones, AL; Kelleher, SM; Parbhoo, SP | 1 |
Buscombe, JR; Cwikla, JB; Hilson, AJ; Thakrar, DS | 1 |
Becherer, A; Helbich, T; Jakesz, R; Kletter, K; Kubista, E; Lehner, R; Leitha, T; Rudas, M; Staudenherz, A; Teleky, B | 1 |
Carriero, MV; Ciarmiello, A; D'Aiuto, G; Del Vecchio, S; Mainolfi, C; Pace, L; Potena, MI; Salvatore, M; Thomas, R; Tsuruo, T | 1 |
Camargo, EE; Coudry, R; Joaquim, AI; Ramos, CD; Sagarra, AJ; Sagarra, RA | 1 |
Ataoğlu, O; Atasever, T; Atavci, S; Unlü, M; Vural, G; Yenidünya, S | 1 |
Awane, H; Kitai, T; Kosumi, T; Ohta, H; Shintaku, M; Ukikusa, M; Yamamoto, S | 1 |
Blocklet, DC; Lenaers, A; Schoutens, AC; Seret, AE; Servais, F | 1 |
Delpassand, ES; Jackson, EF | 1 |
Khalkhali, I | 1 |
Cutrone, J; Diggles, L; Khalkhali, I; Klein, S; Mishkin, F; Stuntz, M; Tolmos, J; Vargas, H; Venegas, R | 1 |
Hahn, K; Khalkhali, I; Meyer, G; Moser, R; Pfluger, T; Sommer, H; Tatsch, K; Tiling, R; Willemsen, F | 1 |
Cannas, P; Colella, AC; Danieli, R; Picardi, V; Schillaci, O; Scopinaro, F; Tavolaro, R | 1 |
Hillner, BE | 1 |
Benevolo, M; Botti, C; Cavaliere, R; Ferranti, F; Grandinetti, ML; Lopez, M; Maini, CL; Mottolese, M; Sciuto, R; Semprebene, A; Tofani, A; Vici, P | 1 |
Akçay, MN; Akin, Y; Karabağ, B; Oren, D; Ozcan, O | 1 |
Coleman, RE; Greer, KL; Jaszczak, RJ; Li, J; Scarfone, C; Smith, MF; Soo, MS | 1 |
Barbarics, E; Cohen, D; Croop, JM; Davison, A; Jones, AG; Kronauge, JF | 1 |
Cohen, M; Lelcuk, S; Lubin, E; Mekhmandarov, S; Sandbank, J | 1 |
Bellò, M; Bessone, M; Bisi, G; Bonazzi, G; Cistaro, A; Coluccia, C; Massaioli, N; Tetti, M; Villata, E | 1 |
David, V; De Vincentis, G; Ierardi, M; Maggi, S; Mezi, S; Modesti, M; Sallusti, E; Scopinaro, F; Tiberio, NS | 1 |
Ambrus, E; Csernay, L; Ormándi, K; Pávics, L; Séra, T; Tószegi, A | 1 |
Hahn, K; Khalkhali, I; Linke, R; Moser, R; Pfluger, T; Sommer, H; Tatsch, K; Tiling, R; Willemsen, F | 1 |
Cutrone, JA; Devito, A; Diggles, L; French, S; Khalkhali, I; Shitabata, P; Tolmos, J; Vargas, MP; Yospur, LS | 1 |
Cantin, J; Lambert, R; Léveillé, J; Robidoux, A; Taillefer, R; Turpin, S | 1 |
Biersack, HJ; Bischof-Delaloye, A; Bourgeois, P; Hilson, AJ; Hustinx, R; Lastoria, S; Maublant, J; Palmedo, H; Prats, E; Stegner, HE | 1 |
Banzo, I; Blanco, I; Carril, JM; Gutiérrez-Mendiguchía, C; Hernández, A; Quirce, R; Uriarte, I; Vega, A | 1 |
Buscombe, JR; Crow, J; Cwikla, JB; Deery, AR; Hilson, AJ; Hinton, J; Kelleher, SM; Parbhoo, SP; Thakrar, DS | 1 |
Botti, G; Carriero, MV; Ciarmiello, A; D'Aiuto, G; Del Vecchio, S; Potena, MI; Salvatore, M; Silvestro, P; Thomas, R | 1 |
Gebauer, K; Hahn, K; Khalkhali, I; Linke, R; Meyer, G; Münzing, W; Pechmann, M; Sommer, H; Tatsch, K; Tiling, R | 1 |
Bautz, W; Hagedorn, K; Kat, S; Krämer, S; Lang, N; Schulz-Wendtland, R; Wolf, F | 1 |
Cacciafesta, M; De Vincentis, G; Gianni, W; Marigliano, V; Pani, R; Pellegrini, R; Scopinaro, F; Soluri, A; Troisi, G | 1 |
Abós, M; Aisa, F; Asenjo, M; Banzo, J; García-López, F; Prats, E; Razola, P; Sainz, J; Tomás, A; Villavieja, L | 1 |
Cutrone, JA; Diggles, LE; Khalkhali, I; Klein, SR; Mishkin, FS; Stuntz, M; Tolmos, J; Vargas, HI; Venegas, RJ; Wang, B | 1 |
Bekdik, CF; Elahi, N; Ergün, EL; Kostakoglu, L; Ruacan, S; Sayek, I | 1 |
Derebek, E | 1 |
Flanagan, DA; Gladding, SB; Lovell, FR | 1 |
Awane, H; Ohta, H; Saito, T; Shintaku, M; Ukikusa, M; Yamamoto, S | 1 |
Cuocolo, A; Klain, M; Maurea, S; Salvatore, M | 1 |
Fukushima, K; Ishii, K; Sakai, E | 1 |
Alonso, O; Bazzano, C; De Boni, D; Delgado, L; Espasandín, J; Garcés, M; Lago, G; Martinez, M; Muse, IM; Mut, F; Núñez, M; Priario, J; Roca, R; Touya, E | 1 |
Blocklet, D; Jijakli, H; Malaisse, WJ; Schoutens, A; Sener, A | 1 |
Barbarics, E; Davison, A; Jones, AG; Kronauge, JF | 1 |
Banzo, J; Carril, J; Gtemegmmt, YE; Herranz, R; Meroño, E; Prats, E | 1 |
Neumann, DP; Weiner, RE; Ziewacz, JT | 1 |
Evans, AJ | 1 |
He, J; Li, Y; Su, J | 1 |
Aburano, T; Endo, K; Enomoto, K; Fukumitsu, N; Konishi, J; Kubo, A; Kusakabe, K; Masuda, K; Narabayashi, I; Nishimura, T; Oshima, M; Takami, H; Tonami, N | 1 |
Blocklet, D; Schoutens, A; Seret, A | 1 |
Botti, C; de Notaristefani, F; Frezza, F; Giunta, S; Iacopi, F; Maini, CL; Malatesta, T; Natali, PG; Sciuto, R; Semprebene, A; Tofani, A; Vittori, F | 1 |
Enomoto, K; Fujii, H; Ikeda, T; Kitajima, M; Kubo, A; Kubota, T; Matsuzaki, SW; Nakamura, K | 1 |
Abós, MD; Aisa, F; Asenjo, MJ; Banzo, J; García-López, F; Prats, E; Razola, P; Villavieja, L | 1 |
Artus, JC; Corone, C; Giammarile, F; Maublant, J; Resche, I | 1 |
Biersack, HJ; Grünwald, F; Mallmann, P; Palmedo, H | 1 |
Dschietzig, C; Richter, M; Riedel, HH; Romann, D | 1 |
Cho, J; Freeman, LM; Guha, C; Lai, PP; Sinha, P | 1 |
Agren, B; Aspelin, P; Boné, B; Danielsson, R; Svensson, L | 1 |
Gal, R; Koren, R; Laver, O; Melloul, M; Michalevich, D; Ohana, G; Paz, A; Wolloch, Y | 1 |
Ballinger, JR; Moore, MJ; Muzzammil, T | 1 |
Buscombe, JR; Cwikla, JB; Hilson, AJ; Parbhoo, SP; Thakrar, DS | 1 |
Chen, EM; Cutrone, JA; Diggles, LE; Khalkhali, I; Mishkin, F | 1 |
Dietlein, M; Lauterbach, KW; Scheidhauer, K; Schicha, H | 1 |
Bom, HS; Jaegal, YJ; Lee, JH; Song, HC; Yoon, JH | 1 |
Arslan, N; Bayhan, H; Ilgan, S; Karaçalioglu, O; Oztürk, E; Pekcan, M; Tufan, T; Urhan, M | 1 |
Drucker, MJ; Dunnwald, LK; Ellis, GK; Gralow, JR; Livingston, RB; Mankoff, DA | 1 |
Aspelin, P; Boné, B; Danielsson, R; Gad, A; Sylvan, M | 1 |
Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A | 1 |
Abdel-Nabi, HH; Diggles, LE; Khalkhali, I; Peller, PJ; Taillefer, R; Vandestreek, PR | 1 |
Mangkharak, J | 1 |
Alakavuklar, M; Alanyali, H; Balci, P; Canda, T; Capa, G; Degirmenci, B; Derebek, E; Durak, H; Gorken, IB; Kocdor, MA | 1 |
Cohenpour, M; Horne, T; Mindlin, L; Orda, R; Pappo, I | 1 |
Aspelin, P; Boné, B; Danielsson, R; Perbeck, L | 1 |
Klimberg, VS; Smith, LF | 1 |
Bui, F; Cagnato, P; Favia, G; Lumachi, F; Marzola, MC; Polistina, F; Zucchetta, P | 1 |
Mann, A | 1 |
Allen, MW; Bassett, L; Gambhir, SS; Hendi, P; Phelps, ME | 1 |
Clarke, EA; Harding, LK; Notghi, A | 1 |
De Vincentis, G; Pani, R; Pellegrini, R; Porfiri, LM; Scopinaro, F; Soluri, A | 1 |
Arslan, N; Bayhan, H; Ilgan, S; Ozturk, E | 1 |
Clark, D; Howarth, D; Lan, L; Sillar, R | 1 |
Edell, S; Heller, L; Rubin, J; Squires, F; Zegel, H | 1 |
Fliquete Peris, MV; Giménez Climent, J; Más Arcas, C; Vázquez Albaladejo, C; Vázquez Forner, C | 1 |
Berger, A; Berghammer, P; Granegger, S; Hohlagschwandtner, M; Kubista, E; Kucera, H; Obwegeser, R; Rodrigues, M; Singer, C; Sinzinger, H | 1 |
Han, S; Kim, BS; Kim, JS; Koh, IH; Park, K | 1 |
Arvay, K; Ferrante, J; Park, YH; Robinson, RE | 1 |
Inoue, Y; Kashima, M; Katayama, N; Ohtomo, K; Shimizu, T; Tsukune, Y; Yoshikawa, K; Yoshioka, N | 1 |
Arrick, B; Kuhn, JC; Poplack, S; Siegel, A | 1 |
Benevolo, M; Botti, C; Festa, A; Giunta, S; Maini, CL; Mottolese, M; Pasqualoni, R; Sciuto, R; Semprebene, A; Tofani, A | 1 |
Knoll, P; Köhn, H; Lipp, RW; Mirzaei, S | 1 |
Ballinger, JR; Melo, T; Tannock, IF; Tunggal, JK | 1 |
Jacobsson, H; Johansson, L; Larsson, SA; Von Schoultz, E; Wilczek, B | 1 |
Arslan, N; Bayhan, H; Dundar, S; Ilgan, S; Narin, Y; Ozturk, E; Pekcan, M; Tufan, T | 1 |
Ho, YJ; Hsieh, JF; Kao, CH; Lee, JK; Sun, SS; Tsai, SC | 1 |
Islam, QT; Karimeddini, MK; Kurtzman, SH; Spencer, RP; Vento, JA | 1 |
Alonso, O; Cánepa, J; Guisoli, P; Lago, G; Mut, F; Núñez, M; Touya, E | 1 |
Bodart, F; de Ruyver, D; Eeckhoudt, L; Fauconnier, JP; François, D; Gérard, R; Hermans, J; Merlo, P; Schmitz, A | 1 |
Christodoulidou, J; Feda, H; Keramopoulos, A; Louvrou, A; Michalas, S; Pampouras, G; Papantoniou, V; Sotiropoulou, M; Stipsaneli, E; Zerva, C | 1 |
D'Eredità, G; Rubini, G | 1 |
Cytron, S; Gal, R; Koren, R; Melloul, M; Michalevich, D; Ohana, G; Paz, A; Wolloch, Y | 1 |
Aldrete, KD; Klaus, AJ; Klingensmith, WC; Parker, SH; Stavros, AT; Sutherland, JD | 1 |
Schillaci, O; Scopinaro, F | 1 |
Andersen, TT; Bennett, JA; Dansereau, RN; Festin, SM; Feustel, PJ; Line, BR; Lukasiewicz, RL; Zhu, S | 1 |
Aziz, A; Hashmi, R; Hayashi, K; Ogawa, Y | 1 |
Parham, CA; Pisano, ED | 1 |
Ali, H; Lefebvre, B; Nachar, O; Ouellet, R; Rioux, A; Rousseau, JA; van Lier, JE | 1 |
Allen, MW; Bassett, L; Gambhir, SS; Hendi, P; Schwimmer, J | 1 |
Fuster, D; Martin, F; Mateos, JJ; Muñoz, M; Ortega, M; Pons, F; Vidal, S | 1 |
Berghammer, P; Chehne, F; Kalinowska, W; Rodrigues, M; Sinzinger, H; Zielinski, C | 1 |
Boné, B; Danielsson, R; Grabowska, A; Reihnér, E | 1 |
Buscombe, JR; Cwikla, JB; Hilson, AJ; Kolasinska, A | 1 |
Mishkin, FS; Mlikotic, A | 1 |
Abad, L; Castellón, MI; Claver, MA; Mulero, F; Nicolás, F; Nuño de la Rosa, JA | 1 |
Abad, L; Castellón, I; Fuentes, T; Illana, J; Mulero, F; Nicolás, F; Nuño de la Rosa, JA; Roca, V | 1 |
Abad, L; Castellón, MA; Claver, MA; de La Cruz, P; Mulero, F; Nicolás, F; Nuño De La Rosa, JA; Roca, V | 1 |
Abad, L; Castellón, MI; de la Cruz, P; Fuentes, T; Mulero, F; Nicolás, F; Nuño de La Rosa, JA; Roca, V | 1 |
Baum, JK; Connolly, JL; Edell, SL; Haber, SB; Houlihan, MJ; Jenkins, RM; Khalkhali, I; Schnitt, SJ; Villanueva-Meyer, J | 1 |
Chisin, R; Klein, M; Moshe, S; Peretz, T; Weininger, J | 1 |
Banzo, J; Dolores Abós, M; García López, F; Prats, E; Razola, P | 1 |
Ahdoot, R; Diggles, L; Kalinowski, EA; Marcus, CS; Minami, C; Moody, T; Pallela, V; Pham, HL; Saeed, S; Thakur, ML | 1 |
Buscombe, JR; Cwikla, JB; Hilson, AJ; Holloway, B | 1 |
Del Vecchio, S; Di Gennaro, F; Di Salle, F; Imbriaco, M; Pace, L; Riccardi, A; Salvatore, M; Sodano, A | 1 |
ChangLai, SP; Ho, ST; Ho, YJ; Kao, CH; Liu, TJ; Tsai, SC; Wang, JJ | 1 |
Ballinger, JR | 1 |
Fülöp, B; Garai, I; Garami, Z; Lukács, G; Tanyi, J; Tanyi, M | 1 |
Irie, A; Nishiyama, Y; Ohkawa, M; Ono, Y; Satoh, K; Yamamoto, Y; Yamauchi, A | 1 |
Ardine, M; Bellò, M; Bessone, M; Bisi, G; Bonazzi, G; Cistaro, A; Coluccia, C; Massaioli, N; Moz, G; Tetti, M; Villata, E | 1 |
Brandes, AA; Bui, F; Ferretti, G; Geatti, O; Lumachi, F; Marzola, MC; Povolato, M; Zucchetta, P | 2 |
Bourguet, P; Buvat, I; Di Paola, R; Laffont, S; Le Cloirec, J | 1 |
Boz, A; Dalmaz, G; Garipağaoğlu, M; Güngör, F; Yildiz, A | 1 |
Lupattelli, G; Palumbo, B; Sinzinger, H | 1 |
Jochelson, M | 1 |
Kalinowska, W; Rodrigues, M; Sinzinger, H; Zielinski, C | 1 |
Torkzad, MR | 1 |
Aguayo, JL; Aguilar, J; Andrés, B; Muelas, M; Nicolás, F; Pérez-Flores, D | 1 |
Brinkbäumer, K; Fieber, S; Hahn, K; Linke, R; Richter, A; Tatsch, K; Tiling, R; Untch, M | 1 |
Akaydin, M; Boz, A; Colak, T; Güngör, F; Ozuğur, S; Tunçdemir, F; Yildiz, A | 1 |
Azaloux, H; Crepin, M; Di Benedetto, M; Kouyoumdjian, JC; Kraemer, M; Moretti, JL; Vergote, J | 1 |
Jaouen, G; Le Bideau, F; Salmain, M; Top, S | 1 |
Baumer, M; Cohen-Pour, M; Horne, T; Orda, R; Pappo, I | 1 |
Miyoshi, Y; Noguchi, S; Taguchi, T; Takamura, Y | 1 |
Christodoulidou, J; Keramopoulos, A; Lazaris, D; Louvrou, A; Michalas, S; Pampouras, G; Papadaki, E; Papantoniou, V; Sotiropoulou, M; Stipsanelli, A; Valotassiou, V; Zerva, C | 1 |
Mirzaei, S | 1 |
Bernard, AM; Bourguet, P; Devillers, A; Garin, E; Girault, S; Laffont, S; Moisan, A; Schill, O | 1 |
Péley, G | 1 |
Deswal, S; Gambhir, S; Singh Sethi, R | 1 |
Knoll, P; Köhn, H; Lipp, RW; Mirzaei, S; Zajicek, SM | 1 |
Karkavitsas, N; Koukouraki, S; Koukourakis, MI; Tsiftsis, D; Vagios, E; Velidaki, A | 1 |
Alonso, O; Delgado, LB; Horvath, J; Kabasakal, L; Llamas-Olier, A; Massardo, T; Maunda, KK; Morales, R; Padhy, AK; Shankar, UR | 1 |
Camerer, B; Friedl, L; Hahn, K; Heiss, DT; Kandziora, C; Leinsinger, GL; Pfluger, T; Scherr, MK; Sommer, H; Tiling, R | 1 |
Buscombe, JR; Cwikla, JB; Davidson, T; Hilson, AJ; Holloway, B; McDermott, N; Parbhoo, SP | 1 |
Fonseca, LM; Gutfilen, B | 1 |
Bellet, N; Fuster, D; Martín, F; Mateos, JJ; Muñoz, M; Ortega, M; Palacín, A; Pavia, J; Pons, F; Setoain, FJ | 1 |
Agbunag, RV; Diggles, L; Kalinowski, A; Khalkhali, I; Klein, SR; Tolmos, J; Vargas, HI | 1 |
Chen, J; Chen, S; Liu, W; Mao, Y; Sun, X; Xiu, Y; Yao, Z; Yin, Y; Zhu, W | 1 |
Shaffer, P | 1 |
Chen, J; Chen, S; Yin, Y | 1 |
Chen, D; Li, C; Qu, X; Wang, Y | 1 |
Coover, LR; Malaspina, PJ | 1 |
Leidenius, MH; Leppänen, EA; Tykkä, HT; von Smitten, KA | 1 |
Maesen, B; Mager, HJ; Schramel, F; Verzijlbergen, F | 1 |
Palmedo, H | 1 |
Chaudhary, KS; Glass, DM; Harrington, KJ; Lalani, el-N; Mubashar, M; Peters, AM; Sinnett, D; Stamp, GW | 1 |
Durmus Altun, G; Hacimahmutoglu, S; Omer Yigitbasi, N; Pekindil, G; Sarikaya, A; Uzal, C | 1 |
Cachin, F; Cayre, A; Chevillard, S; Feillel, V; Ferrière, JP; Finat-Duclos, F; Kwiaktowski, F; Maublant, J; Mestas, D; Penault-Llorca, F; Verrelle, P | 1 |
Christodoulidou, J; Feida, H; Louvrou, A; Michalas, S; Pampouras, G; Papadaki, E; Papantoniou, V; Sotiropoulou, M; Souvatzoglou, M; Valotassiou, V; Zerva, C | 1 |
Kao, A; Lee, CC; Lin, CC; Sun, SS; Wang, HC | 1 |
Aloj, L; Botti, G; Caracò, C; Ciarmiello, A; D'Aiuto, G; Del Vecchio, S; Fonti, R; Salvatore, M; Zannetti, A | 1 |
Aras, G; Arican, P; Cam, R; Ibiş, E; Küçük, NO; Soylu, A; Tüzüner, A | 1 |
Belli, F; Bergomi, S; Botti, C; Maini, CL; Mottolese, M; Pasqualoni, R; Petrilli, G; Sciuto, R; Vici, P | 1 |
Buscombe, JR | 1 |
Alonso, O; Delgado, L; González, P; Kabasakal, L; Llamas-Olier, A; Massardo, T; Mut, F; Padhy, AK; Shankar, UR; Zhu, H | 1 |
Brem, RF; Civelek, C; Goodman, S; Kieper, DA; Majewski, S; Schoonjans, JM | 1 |
Lastoria, S; Muto, P; Piccolo, S | 1 |
Campeau, RJ; Kronemer, KA; Sutherland, CM | 1 |
40 review(s) available for technetium tc 99m sestamibi and Breast Cancer
Article | Year |
---|---|
Topics: Breast Neoplasms; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2022 |
Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Mammography; Neoadjuvant Therapy; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi; Treatment Outcome | 2018 |
Molecular Breast Imaging: A Comprehensive Review.
Topics: Breast; Breast Neoplasms; Female; Humans; Molecular Imaging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2018 |
Molecular breast imaging with gamma emitters.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Molecular Imaging; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2013 |
Molecular imaging for the characterization of breast tumors.
Topics: Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mammography; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Mammography; Middle Aged; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2016 |
Mammographic Breast Density and Breast Cancer Risk: Implications of the Breast Density Legislation for Health Care Practitioners.
Topics: Breast Density; Breast Neoplasms; Early Detection of Cancer; Female; Humans; Legislation as Topic; Magnetic Resonance Imaging; Mammography; Molecular Imaging; Radionuclide Imaging; Risk Factors; Technetium Tc 99m Sestamibi; Ultrasonography | 2016 |
Breast Imaging Utilizing Dedicated Gamma Camera and (99m)Tc-MIBI: Experience at the Tel Aviv Medical Center and Review of the Literature Breast Imaging.
Topics: Academic Medical Centers; Breast; Breast Neoplasms; Humans; Israel; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2016 |
Molecular breast imaging.
Topics: Breast Neoplasms; Clinical Trials as Topic; Female; Gamma Cameras; Humans; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2009 |
Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Data Interpretation, Statistical; Female; Humans; Middle Aged; Odds Ratio; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2011 |
New modalities in breast imaging: digital mammography, positron emission tomography, and sestamibi scintimammography.
Topics: Breast Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Mammography; Radiographic Image Enhancement; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Telemedicine; Tomography, Emission-Computed | 2002 |
A review of the cost-effectiveness of Tc-99m sestamibi scintimammography in diagnosis of breast cancer in Taiwanese women with indeterminate mammographically dense breast.
Topics: Biopsy; Breast Neoplasms; Cost-Benefit Analysis; Decision Trees; Female; Humans; Mammography; Radiopharmaceuticals; Taiwan; Technetium Tc 99m Sestamibi | 2002 |
The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.
Topics: Breast Neoplasms; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2003 |
MIBI as prognostic factor in breast cancer.
Topics: Breast Neoplasms; Humans; Metabolic Clearance Rate; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Outcome | 2003 |
Tetrofosmin as predictors of tumour response.
Topics: Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Failure; Treatment Outcome | 2003 |
Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.
Topics: Axilla; Breast Neoplasms; Cations; Humans; Lymph Nodes; Lymphatic Metastasis; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
99mTc-MIBI in the evaluation of breast cancer biology.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Humans; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions.
Topics: Breast Neoplasms; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2004 |
Clinical applications of 99mTc-sestamibi scintimammography.
Topics: Breast Neoplasms; Humans; Lymphatic Metastasis; Mammography; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Thallium-201 uptake in lung cancer.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lung Neoplasms; Middle Aged; Octreotide; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Thoracic Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.
Topics: Adult; Breast Neoplasms; Diagnostic Imaging; Female; Humans; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 1994 |
[Nuclear medical breast diagnosis--scintigraphy using 99mTc-sestamibi].
Topics: Biopsy; Breast; Breast Diseases; Breast Neoplasms; Female; Humans; Mammography; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Nuclear medicine techniques in breast imaging.
Topics: Breast Neoplasms; Female; Humans; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Nuclear medicine imaging of breast cancer.
Topics: Biopsy; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Mammography; Octreotide; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed | 1996 |
Scintigraphic imaging of breast tumors.
Topics: Breast Neoplasms; Clinical Trials as Topic; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
Technologic advances in breast imaging. Current and future strategies, controversies, and opportunities.
Topics: Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Humans; Magnetic Resonance Imaging; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography | 1997 |
The role of (99m)Tc methoxyisobutylisonitrile in imaging breast cancer.
Topics: Breast Neoplasms; Female; Humans; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Scintimammography: the new role of technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.
Topics: Breast; Breast Neoplasms; Female; Humans; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
[Progresses in nuclear medicine in China, 1996].
Topics: Breast Neoplasms; Cellular Senescence; Humans; Neoplasms; Radionuclide Imaging; Spectrometry, X-Ray Emission; Technetium Tc 99m Sestamibi | 1996 |
Scintigraphic imaging of breast cancer: a review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Organophosphorus Compounds; Organotechnetium Compounds; Receptors, Estrogen; Receptors, Somatostatin; Reproducibility of Results; Technetium Tc 99m Sestamibi; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed | 1997 |
[The role of 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1998 |
Dynamic imaging: scintimammography.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Mammography; Phenotype; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
The difficult breast.
Topics: Biopsy; Breast Neoplasms; Costs and Cost Analysis; Diagnostic Imaging; Female; Humans; Magnetic Resonance Imaging; Mammography; Mass Screening; Minimally Invasive Surgical Procedures; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 1999 |
The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis.
Topics: Breast Neoplasms; Female; Humans; Mammography; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[Nuclear oncology update].
Topics: Bone Neoplasms; Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Organometallic Compounds; Organophosphorus Compounds; Peptides; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Tc-99m sestamibi scintimammography: where is it now?
Topics: Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Digital mammography, sestamibi breast scintigraphy, and positron emission tomography breast imaging.
Topics: Breast; Breast Neoplasms; Data Display; Diagnosis, Computer-Assisted; Female; Humans; Image Processing, Computer-Assisted; Mammography; Radiographic Image Enhancement; Radiology Information Systems; Radiopharmaceuticals; Subtraction Technique; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2000 |
[Breast scintigraphy].
Topics: Adult; Artifacts; Axilla; Biopsy; Breast Diseases; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Drug Resistance, Multiple; Drug Resistance, Neoplasm; False Positive Reactions; Female; Forecasting; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Organophosphorus Compounds; Organotechnetium Compounds; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Ultrasonography | 2001 |
Breast cancer imaging: the future.
Topics: Breast Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Ultrasonography | 2001 |
Monitoring therapy in breast cancer.
Topics: Breast Neoplasms; Female; Humans; Monitoring, Physiologic; Neoplasm Recurrence, Local; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Estrogen; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
62 trial(s) available for technetium tc 99m sestamibi and Breast Cancer
Article | Year |
---|---|
Patient Acceptance of Half-dose Vs. Half-time Molecular Breast Imaging.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Molecular Imaging; Patient Acceptance of Health Care; Patient Preference; Radiation Dosage; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 2018 |
Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.
Topics: Administration, Oral; Adult; Breast; Breast Density; Breast Neoplasms; Feasibility Studies; Female; Gamma Cameras; Humans; Mammography; Middle Aged; Molecular Imaging; Pilot Projects; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Tamoxifen; Technetium Tc 99m Sestamibi; Time Factors | 2019 |
99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Molecular Imaging; Neoadjuvant Therapy; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome; Tumor Burden | 2013 |
Axillary lymph node staging in breast cancer: clinical value of single photon emission computed tomography-computed tomography (SPECT-CT) with 99mTc-methoxyisobutylisonitrile.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
Technetium-99m methoxyisobutylisonitrile scintimammography for monitoring and early prediction of breast cancer response to neoadjuvant chemotherapy.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2015 |
The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid.
Topics: Adult; Antimony; Breast Neoplasms; Colloids; Female; Humans; Injections; Neoplasm Staging; Radionuclide Imaging; Sentinel Lymph Node Biopsy; Technetium Compounds; Technetium Tc 99m Sestamibi | 2010 |
Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
Identification of angiogenesis in primary breast carcinoma according to the image analysis.
Topics: Adult; Aged; Breast Neoplasms; Endothelial Growth Factors; Female; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mammography; Middle Aged; Neovascularization, Pathologic; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.
Topics: Blood Flow Velocity; Breast Neoplasms; Female; Humans; Models, Biological; Oxygen Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi; Water | 2002 |
Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Palpation; Postmenopause; Predictive Value of Tests; Premenopause; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
99mTc sestamibi scintimammography in the diagnosis of palpable breast masses.
Topics: Adult; Breast; Breast Neoplasms; Female; Humans; Palpation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
The usefulness of 99mTc tetrofosmin scintigraphy in patients with breast cancer recurrences.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Breast; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Contribution of 99mTc-anti-carcinoembryonic antigen antibody and 99mTc-sestamibi scintimammography in the evaluation of high risk palpable breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Immunoglobulin Fab Fragments; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Statistics as Topic; Technetium Tc 99m Sestamibi | 2003 |
International prospective evaluation of scintimammography with (99m)technetium sestamibi.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi | 2003 |
Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers, and infiltrating breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Diagnosis, Differential; Dipyridamole; Female; Humans; Male; Mastitis; Middle Aged; Mitochondria; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Regional Blood Flow; Technetium Tc 99m Sestamibi; Vasodilator Agents | 2002 |
Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
Topics: Adult; Age Factors; Aged; Breast Diseases; Breast Neoplasms; Calcinosis; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic diagnoses.
Topics: Breast; Breast Neoplasms; Diagnostic Errors; False Negative Reactions; False Positive Reactions; Female; Humans; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
Monitoring the response of large (>3 cm) and locally advanced (T3-4, N0-2) breast cancer to neoadjuvant chemotherapy using (99m)Tc-Sestamibi uptake.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Humans; Image Interpretation, Computer-Assisted; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Taxoids; Technetium Tc 99m Sestamibi; Treatment Outcome | 2005 |
Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Topics: Aged; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Immunohistochemistry; Mammography; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2005 |
Identification of sentinel lymph node in stage I-II breast cancer with lymphoscintigraphy and surgical gamma probe: comparison of Tc-99m MIBI and Tc-99m sulfur colloid.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sestamibi; Technetium Tc 99m Sulfur Colloid | 2005 |
Comparison of early and delayed quantified indices of double-phase (99m)Tc MIBI scintimammography in the detection of primary breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Technetium Tc 99m Sestamibi; Time Factors | 2005 |
Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Relationship between prognostic factors of breast cancer and 99mTc-sestamibi uptake in patients who underwent scintimammography: Multivariate analysis of causes of false-negative results.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; False Negative Reactions; Female; Humans; Mammography; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2006 |
Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Quinolines; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2005 |
[Evaluation of response to neoadjuvant chemotherapy using breast scintigraphy in breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
Topics: Adult; Aged; Algorithms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2006 |
Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Neoplasm Invasiveness; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 1994 |
[Breast scintigraphy with technetium 99m sestamibi, as support to radiologic methods in the study of breast lesions].
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Radiography; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
Scintimammography with Tc-99m MIBI in patients with suspicion of primary breast cancer.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclosporins; Cystadenocarcinoma; Drug Resistance, Multiple; Female; Humans; Kidney; Liver; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients.
Topics: Axilla; Biopsy; Breast Neoplasms; Carcinoma; False Negative Reactions; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mammography; Mastectomy, Modified Radical; Mastectomy, Segmental; Neoplasm Staging; Physical Examination; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Scintimammography with Tc-99m sestamibi.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Breast; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fibroadenoma; Humans; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Epirubicin; Female; Humans; Lymph Node Excision; Mastectomy, Modified Radical; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
[A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Evaluation Studies as Topic; Female; Fibroadenoma; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Spain; Technetium Tc 99m Sestamibi | 1998 |
[Evaluation of clinical utility of 99mTc-MIBI scintigraphy in the localization of thyroid, breast and lung/mediastinum tumors--a report of multicenter phase III clinical trials].
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thyroid Neoplasms | 1998 |
Results of the European multicenter study of radionuclide mammography with Tc-99m-MIBI.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Europe; Female; Humans; Mammography; Middle Aged; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Prone SPET scintimammography.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Mammography; Middle Aged; Prone Position; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Feasibility Studies; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Monitoring, Physiologic; Neoadjuvant Therapy; Reproducibility of Results; Technetium Tc 99m Sestamibi; Treatment Outcome | 1999 |
A study on the cost effectiveness of sestamibi scintimammography for screening women with dense breasts for breast cancer.
Topics: Adult; Breast; Breast Neoplasms; Cost-Benefit Analysis; Decision Trees; Female; Humans; Mammography; Mass Screening; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Can reduced imaging times be used for scintimammography?
Topics: Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Mammography; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 1999 |
High-resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera.
Topics: Aged; Algorithms; Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
A head-to-head comparison between technetium-99m-tetrofosmin and technetium-99m-MIBI scintigraphy to evaluate suspicious breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Immunohistochemistry; Middle Aged; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
Tc-99m MIBI in suspected recurrent breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Recurrence, Local; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2000 |
Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
Topics: Biopsy; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Observer Variation; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses.
Topics: Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Mammography; Middle Aged; Models, Statistical; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2001 |
Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection.
Topics: Adult; Aged; Axilla; Biopsy, Needle; Breast Neoplasms; Chi-Square Distribution; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Probability; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Radiopharmaceuticals; Reference Standards; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2001 |
99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Comparison of Tc-99m THY and Tc-99m MIBI scans for diagnosis of breast lesions.
Topics: Breast Diseases; Breast Neoplasms; Female; Humans; Mammography; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thymine | 2001 |
International prospective evaluation of scintimammography with technetium-99m sestamibi: interim results.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Cohort Studies; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Immunohistochemistry; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
The role of Tc99m-sestamibi scintimammography in combination with the triple assessment of primary breast cancer.
Topics: Aged; Biopsy, Needle; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Neoplasm Staging; Radiographic Image Enhancement; Radionuclide Imaging; Sensitivity and Specificity; Statistics, Nonparametric; Technetium Tc 99m Sestamibi; Ultrasonography | 2002 |
Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Pleural Effusion, Malignant; Pleurodesis; Prospective Studies; Talc; Technetium Tc 99m Sestamibi; Thoracic Duct; Thoracoscopy; Treatment Outcome | 2002 |
Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Mastectomy, Radical; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Treatment Outcome | 2002 |
Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Topics: Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2002 |
356 other study(ies) available for technetium tc 99m sestamibi and Breast Cancer
Article | Year |
---|---|
Incidental detection of breast cancer by 18F-fluorocholine PET/CT performed for primary hyperparathyroidism.
Topics: Breast Neoplasms; Choline; Female; Humans; Hyperparathyroidism, Primary; Parathyroid Glands; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2022 |
Updates in Molecular Breast Imaging.
Topics: Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Molecular Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2022 |
Downstream imaging following abnormal molecular breast imaging, lessons learned and suggestions for success.
Topics: Breast Neoplasms; Female; Humans; Mammography; Molecular Imaging; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Sestamibi | 2022 |
Monte Carlo-derived
Topics: Breast Neoplasms; Female; Humans; Mammography; Phantoms, Imaging; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2023 |
Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnormalities and unresolved diagnostic concerns.
Topics: Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Predictive Value of Tests; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2023 |
Did we solve soft tissue (breast) attenuation?
Topics: Artifacts; Breast; Breast Neoplasms; Coronary Artery Disease; False Positive Reactions; Female; Humans; Image Processing, Computer-Assisted; Male; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Phantoms, Imaging; Prognosis; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2021 |
Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Molecular Imaging; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2019 |
Comparison of
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary; Young Adult | 2020 |
The Clinical Utility of a Negative Result at Molecular Breast Imaging: Initial Proof of Concept.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Negative Results; Proof of Concept Study; Retrospective Studies; Technetium Tc 99m Sestamibi | 2020 |
First Clinical Experience Using Stereotactic Breast Biopsy Guided by
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Image-Guided Biopsy; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Software; Technetium Tc 99m Sestamibi | 2017 |
Correlations between Tumor to Background Ratio on Breast-Specific Gamma Imaging and Prognostic Factors in Breast Cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Gamma Rays; Humans; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Grading; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Technetium Tc 99m Sestamibi | 2017 |
Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
Topics: Adult; Aged; Biopsy, Needle; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Mammography; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tumor Burden; Ultrasonography, Mammary; Young Adult | 2018 |
Experimental validation of absolute SPECT/CT quantification for response monitoring in breast cancer.
Topics: Aged; Breast Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Neoadjuvant Therapy; Phantoms, Imaging; Signal-To-Noise Ratio; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2018 |
Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy.
Topics: Adult; Aged; Breast; Breast Density; Breast Neoplasms; Female; Humans; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2018 |
Evaluation of the Effect of Resveratrol and Doxorubicin on
Topics: Animals; Breast Neoplasms; Doxorubicin; Female; Humans; MCF-7 Cells; Mice; Mice, Nude; Resveratrol; Technetium Tc 99m Sestamibi; Tissue Distribution; Xenograft Model Antitumor Assays | 2018 |
Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
Topics: Adenoma; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2019 |
The use of single-photon emission computed tomography-computed tomography in detecting multiple metastatic lymph nodes in patients with breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2019 |
99mTc sestamibi SPECT: a possible tool for early detection of breast cancer lesions with high bone metastatic potential.
Topics: Bone Neoplasms; Breast Neoplasms; Early Detection of Cancer; Female; Humans; Molecular Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
Breast-Specific Gamma Imaging Versus MRI: Comparing the Diagnostic Performance in Assessing Treatment Response After Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2019 |
Comparison of
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Molecular Imaging; Neoadjuvant Therapy; Neoplasm Invasiveness; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2019 |
Incidental Primary Breast Lymphoma on 99mTc-Sestamibi Myocardial Perfusion Imaging With SPECT/CT.
Topics: Breast Neoplasms; Coronary Artery Disease; Female; Humans; Incidental Findings; Lymphoma; Middle Aged; Myocardial Perfusion Imaging; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi | 2019 |
[Methodologic aspects of radionuclide diagnosis of breast cancer with 99mTc-MIBI].
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2012 |
[Combined use of 99mTc-MIBI scintigraphy and ultrasonography (US) in the diagnosis of axillary lymphatic metastasis in patients with breast cancer].
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Lymphoscintigraphy; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ultrasonography | 2013 |
[Diagnostic accuracy of mammography and mammoscintigraphy in multifocal breast cancer].
Topics: Adult; Aged; Bayes Theorem; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Mammary | 2013 |
Breast-specific gamma imaging (BSGI), molecular breast imaging (MBI), or scintimammography with breast-specific gamma camera.
Topics: Blue Cross Blue Shield Insurance Plans; Breast Neoplasms; Drug Approval; Female; Gamma Cameras; Humans; Mammography; Molecular Imaging; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Technology Assessment, Biomedical; United States; United States Food and Drug Administration | 2013 |
The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Topics: Adult; Aged; Breast; Breast Neoplasms; Calcinosis; Carcinoma, Intraductal, Noninfiltrating; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Image Enhancement; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Gamma Rays; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Organ Specificity; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2014 |
Invasive ductal carcinoma arising from dense accessory breast visualized with 99mTc-MIBI breast-specific γ imaging.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal; Female; Humans; Neoplasm Invasiveness; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2014 |
Breast-specific gamma imaging for the detection of breast cancer in dense versus nondense breasts.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Radionuclide Imaging; ROC Curve; Technetium Tc 99m Sestamibi; Young Adult | 2014 |
Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI.
Topics: Breast Neoplasms; Cost-Benefit Analysis; Female; Gamma Rays; Hospital Charges; Humans; Magnetic Resonance Imaging; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2014 |
Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Topics: Biomarkers; Breast Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Parathyroid Hormone; Parathyroid Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Gamma Cameras; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Surgery, Computer-Assisted; Technetium Tc 99m Sestamibi; Treatment Outcome | 2014 |
Prevalence of perfusion defects detected by stress 99mtechnetium sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Coronary Artery Disease; Female; Humans; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2014 |
Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2015 |
Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT.
Topics: Adult; Aged; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Mammography; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome; Whole Body Imaging | 2017 |
Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI.
Topics: Breast Diseases; Breast Neoplasms; Female; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Mammography; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2015 |
Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.
Topics: Adult; Aged; Breast Neoplasms; Early Detection of Cancer; Female; Health Care Costs; Humans; Mammography; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; United States | 2015 |
Comparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms.
Topics: Breast; Breast Neoplasms; Calibration; Equipment Design; Female; Gamma Cameras; Gamma Rays; Humans; Models, Biological; Molecular Imaging; Phantoms, Imaging; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2015 |
Direct-Conversion Molecular Breast Imaging of Invasive Breast Cancer: Imaging Features, Extent of Invasive Disease, and Comparison Between Invasive Ductal and Lobular Histology.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Humans; Middle Aged; Molecular Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2015 |
[Breast-specific gamma imaging in breast cancer].
Topics: Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Magnetic Resonance Imaging; Mammography; Organ Specificity; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2016 |
Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi | 2016 |
Advancements in Imaging Technology for Detection and Diagnosis of Palpable Breast Masses.
Topics: Breast Neoplasms; Elasticity Imaging Techniques; Female; Gamma Rays; Humans; Lactation; Magnetic Resonance Imaging; Mammography; Nipple Discharge; Palpation; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2016 |
Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Density; Breast Neoplasms; Early Detection of Cancer; Female; Humans; Mammography; Middle Aged; Molecular Imaging; Radiation Dosage; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2016 |
Benefit to Radiation Risk of Breast-specific Gamma Imaging Compared with Mammography in Screening Asymptomatic Women with Dense Breasts.
Topics: Adult; Aged; Breast Density; Breast Neoplasms; Early Detection of Cancer; Female; Gamma Cameras; Humans; Mammography; Middle Aged; Neoplasms, Radiation-Induced; Radiation Dosage; Radiopharmaceuticals; Risk Assessment; Technetium Tc 99m Sestamibi | 2016 |
Retrospective and comparative analysis of (99m)Tc-Sestamibi breast specific gamma imaging versus mammography, ultrasound, and magnetic resonance imaging for the detection of breast cancer in Chinese women.
Topics: Adult; Aged; Breast; Breast Density; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; China; Early Detection of Cancer; Female; Gamma Rays; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography | 2016 |
Breast cancer diagnosed by stress SPECT sestamibi: The role of inverse gray-scale imaging.
Topics: Aged; Breast Neoplasms; Female; Humans; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2017 |
Tc-99m-methoxy isobutyl isonitrile scintimammography: imaging postexcision biopsy for residual and multifocal breast tumor.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Diagnostic Imaging; Female; Humans; Mammography; Medical Oncology; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience.
Topics: Adult; Breast Neoplasms; Equipment Design; False Negative Reactions; False Positive Reactions; Female; Gamma Cameras; Humans; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Comparison of double phase Tc-99m MIBI and Tc-99m tetrofosmin scintimammography for characterization of breast lesions: Visual and quantitative analyses.
Topics: Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi | 2008 |
Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Equipment Design; Equipment Failure Analysis; Female; Gamma Cameras; Humans; Image Enhancement; Middle Aged; Molecular Probe Techniques; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi | 2008 |
Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Breast Neoplasms; Computer Simulation; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression; Genes, BRCA1; Genes, p53; Humans; Mammary Neoplasms, Experimental; Mice; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2009 |
Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Lobular; Contrast Media; Female; Gamma Cameras; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasm Invasiveness; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2009 |
Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Gamma Rays; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2009 |
Dual phase qualitative and quantitative 99mTc-MIBI scintimammography for predicting response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Middle Aged; Neoadjuvant Therapy; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2009 |
Usefulness of combined sestamibi scintimammography, axillary ultrasonography and FNA cytology in reducing the number of sentinel node procedures in patients with early-stage breast cancer.
Topics: Adult; Aged; Biopsy, Fine-Needle; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sestamibi; Ultrasonography | 2009 |
Breast-specific gamma imaging for detection of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Gamma Cameras; Humans; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2009 |
Detection of bilateral, multifocal breast cancer and assessment of tumour response to neoadjuvant chemotherapy by Tc-99m sestamibi imaging - a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Outcome | 2008 |
Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Cross-Sectional Studies; Female; Humans; Male; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary; Young Adult | 2009 |
Detection and prediction of breast cancer using double phase Tc-99m MIBI scintimammography in comparison with MRI.
Topics: Breast Neoplasms; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2009 |
Comparison between 99mTc-sestamibi scintimammography and X-ray mammography in the characterization of clusters of microcalcifications: a prospective long-term study.
Topics: Adult; Aged; Breast Neoplasms; Calcinosis; Female; Humans; Mammography; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2009 |
A (99m)Tc-labeled triphenylphosphonium derivative for the early detection of breast tumors.
Topics: Animals; Breast Neoplasms; Disease Models, Animal; Early Detection of Cancer; Female; Membrane Potential, Mitochondrial; Mitochondria; Models, Chemical; Neoplasm Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Technetium; Technetium Tc 99m Sestamibi | 2009 |
Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera.
Topics: Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Organ Specificity; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2009 |
Interesting image. Tc-99m sestamibi SPECT/CT as a new tool for monitoring perfusion and viability of buried perforator based free flaps in breast reconstruction after breast cancer.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Perfusion Imaging; Radiopharmaceuticals; Surgical Flaps; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Functional breast imaging with Tc 99m Mibi for detection of primary breast lesion and axillary lymph node metastases.
Topics: Adult; Aged; Breast Neoplasms; Diagnostic Imaging; Female; Humans; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Dual-modality breast tomosynthesis.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Diagnosis, Differential; Female; Gamma Cameras; Humans; Middle Aged; Pilot Projects; Predictive Value of Tests; Prospective Studies; Radiographic Image Enhancement; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2010 |
Diagnostic accuracy of (99m)Tc- MIBI for breast carcinoma in correlation with mammography and sonography.
Topics: Breast Neoplasms; Female; Humans; Prognosis; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography; Ultrasonography, Mammary | 2010 |
Scintimammography in conjunction with ultrasonography for local breast cancer recurrence in post-mastectomy breast.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mastectomy, Radical; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thoracic Wall; Ultrasonography, Mammary; Young Adult | 2010 |
Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Middle Aged; Prospective Studies; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2011 |
[Predicative value of 99mTc-MIBI scintimammography in neoadjuvant chemotherapeutic effect of patients with operable breast cancer].
Topics: Adult; Breast Neoplasms; Female; Humans; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2011 |
Prediction of lack of response to neoadjuvant chemotherapy in rare breast tumour histology with Tc-99m sestamibi scintimammography.
Topics: Breast Neoplasms; Carcinoma, Ductal; Diagnostic Errors; Female; Humans; Liposarcoma; Middle Aged; Neoadjuvant Therapy; Preoperative Period; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2011 |
MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial.
Topics: Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Follow-Up Studies; Gamma Cameras; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prospective Studies; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2012 |
Single-photon-emission computed tomography (SPECT) with 99 technetium sestamibi in the diagnosis of small breast cancer and axillary node involvement.
Topics: Breast Neoplasms; Female; Humans; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2011 |
Single-photon-emission computed tomography (SPECT) with technetium-99m sestamibi in the diagnosis of small breast cancer and axillary lymph node involvement.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2011 |
Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI.
Topics: Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnostic Errors; Female; Gamma Rays; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mammography; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2012 |
Effect of asiaticoside on 99mTc-tetrofosmin and 99mTc-sestamibi uptake in MCF-7 cells.
Topics: Anti-Infective Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Metabolic Clearance Rate; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Triterpenes | 2011 |
[Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Taxoids; Technetium Tc 99m Sestamibi | 2011 |
Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Gamma Cameras; Humans; Male; Mammography; Middle Aged; Molecular Imaging; Patient Positioning; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Registries; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2012 |
[Early diagnosis of breast cancer with scintimammography and ultrasound ].
Topics: Breast Neoplasms; Early Detection of Cancer; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2011 |
Evaluation of the relationship between [18F]FDG and P-glycoprotein expression: an experimental study.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Prohibitins; Rhodamine 123; Technetium Tc 99m Sestamibi; Verapamil | 2012 |
Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi.
Topics: Adult; Biopsy; Breast; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Risk Assessment; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome | 2012 |
Abundant blood supply and low P-glycoprotein expression on dynamic 99mTc-MIBI imaging predicted better chemotherapy sensitivity for a breast cancer patient: a case report.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Treatment Outcome | 2012 |
Response of malignant breast tumours to neoadjuvant chemotherapy evaluated with Tc-99m MIBI.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2011 |
[Breast scintigraphy using 99mTc-sestamibi--use and limitations].
Topics: Breast; Breast Neoplasms; Female; Fibrocystic Breast Disease; Humans; Magnetic Resonance Imaging; Mastitis; Papilloma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium Tc 99m Sestamibi | 2002 |
Technetium labeled bombesin-like peptide: preliminary report on breast cancer uptake in patients.
Topics: Aged; Bombesin; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Peptides; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi | 2002 |
Utility of technetium-99m methoxyisobutyl isonitrile uptake analysis for prediction of the response to chemotherapy in advanced and relapsed breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Retrospective Studies; Sampling Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Treatment Outcome; Vinca Alkaloids | 2002 |
Varicose veins demonstrated on sestamibi tumor imaging.
Topics: Aged; Breast Neoplasms; Female; Humans; Leg; Pain; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Varicose Veins | 2002 |
Clinical significance of 99mTc-MIBI breast imaging in the diagnosis of early breast cancer.
Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 2002 |
Breast cancer imaging with PET and SPECT agents: an in vivo comparison.
Topics: Animals; Breast Neoplasms; Fluorodeoxyglucose F18; Metabolic Clearance Rate; Muscle, Skeletal; Neoplasm Transplantation; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
In vitro and in vivo study of 99mTc-MIBI encapsulated in PEG-liposomes: a promising radiotracer for tumour imaging.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Coated Materials, Biocompatible; Female; Humans; Leukemia, Erythroblastic, Acute; Liposomes; Male; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Polyethylene Glycols; Radionuclide Imaging; Radiopharmaceuticals; Rats; Technetium Tc 99m Sestamibi; Tissue Distribution; Whole-Body Counting | 2003 |
Breast cancer: monitoring response to neoadjuvant chemotherapy using Tc-99m sestamibi scintimammography.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Epirubicin; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Mammography; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Treatment Outcome | 2003 |
Comparison of 99mTc-sestamibi scintimammography and dynamic MR imaging as adjuncts to mammography in the diagnosis of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Technetium Tc 99m Sestamibi | 2003 |
Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy.
Topics: Adenocarcinoma; Adenoma; Bone Neoplasms; Breast Neoplasms; Female; Humans; Incidental Findings; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thoracic Neoplasms | 2003 |
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
Topics: Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biological Transport; Breast Neoplasms; Carcinoma, Ductal; Female; Humans; Immunoenzyme Techniques; Immunohistochemistry; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2003 |
In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Inflammation; Middle Aged; Posture; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Early assessment of neoadjuvant chemotherapy by FEC-courses of locally advanced breast cancer using 99mTc-MIBI.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Case-Control Studies; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Radiopharmaceuticals; Stereoisomerism; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 2003 |
Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnostic procedure in palpable and non-palpable breast lesions.
Topics: Biopsy, Needle; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Palpation; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
[Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer].
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Humans; Mammography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2003 |
Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
Topics: Adolescent; Adult; Aged; Axilla; Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2003 |
[Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Lack of correlation between Tc-99m-sestaMIBI uptake and cadherin expression in infiltrating ductal breast carcinoma as prognostic indicators.
Topics: Adult; Biomarkers, Tumor; Breast; Breast Neoplasms; Cadherins; Carcinoma, Ductal; Female; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Sestamibi | 2003 |
Technetium-99m-sestamibi scintimammography to detect breast cancer in patients with paraffinomas or siliconomas after breast augmentation.
Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Data Interpretation, Statistical; False Negative Reactions; False Positive Reactions; Female; Fibroadenoma; Fibrocystic Breast Disease; Granuloma; Humans; Injections; Mammography; Middle Aged; Oils; Paraffin; Sensitivity and Specificity; Silicones; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Mammary | 2003 |
Detection of occult breast carcinoma during evaluation of a skeletal tumor by Tc-99m MIBI scintigraphy.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Humans; Humerus; Incidental Findings; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2003 |
Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Humans; Metabolic Clearance Rate; Multidrug Resistance-Associated Proteins; Organophosphorus Compounds; Organotechnetium Compounds; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2003 |
The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; Kinetics; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2003 |
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.
Topics: Breast Neoplasms; Cell Line, Tumor; Cloning, Molecular; Humans; Metabolic Clearance Rate; Proto-Oncogene Proteins c-bcl-2; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Staurosporine; Technetium Tc 99m Sestamibi; Transfection | 2004 |
99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Calcinosis; Female; Humans; Mammography; Mass Screening; Middle Aged; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2004 |
Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Breast Neoplasms; Cell Proliferation; Female; Humans; Ki-67 Antigen; Mammography; Middle Aged; Radionuclide Imaging; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi; Tumor Suppressor Protein p53 | 2004 |
Breast scintigraphy: procedure guidelines for tumour imaging.
Topics: Breast; Breast Neoplasms; Europe; Humans; Nuclear Medicine; Organophosphorus Compounds; Organotechnetium Compounds; Patient Care Management; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Societies, Medical; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2003 |
Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.
Topics: Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Physical Examination; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
Breast scintigraphy today: indications and limitations.
Topics: Breast Neoplasms; Clinical Trials as Topic; Humans; Lymphatic Metastasis; Organophosphorus Compounds; Organotechnetium Compounds; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Technology Assessment, Biomedical; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2004 |
Using 99mTc-sestamibi to evaluate the effects of a chemosensitizer on P-glycoprotein in multidrug-resistant carcinoma cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Data Interpretation, Statistical; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Technetium Tc 99m Sestamibi; Verapamil | 2004 |
99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Feasibility Studies; Glucaric Acid; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous | 2004 |
[Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Topics: Adolescent; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Multidrug Resistance-Associated Proteins; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report.
Topics: Aged; Breast Neoplasms; Female; Humans; Mammography; Neoplasm Recurrence, Local; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2004 |
Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Head and Neck Neoplasms; Humans; Immunohistochemistry; Mice; Microscopy, Fluorescence; Technetium Tc 99m Sestamibi; Toremifene; Vinblastine | 2004 |
Does 99mTc-sestamibi uptake discriminate breast tumors?
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2004 |
99mTc-exametazime as a breast tumor-seeking agent: comparison with 99mTc-sestamibi.
Topics: Breast Neoplasms; Female; Humans; Radionuclide Imaging; Technetium Tc 99m Exametazime; Technetium Tc 99m Sestamibi | 2004 |
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Breast Neoplasms, Male; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Mammography; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Radionuclide Imaging; Scintillation Counting; Technetium Tc 99m Sestamibi | 2005 |
Use of Tc-99m glucoheptonate scintimammography as a potential alternative for the diagnosis of breast cancer.
Topics: Aged; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Image Enhancement; Mammography; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Sugar Acids; Technetium Tc 99m Sestamibi | 2005 |
Clinical utility of 99mTc-Sestamibi scintimammography in the management of equivocal breast lesions.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Recurrence; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2004 |
Comparison of quantitative and visual analysis of Tc-99m MIBI scintimammography for detection of primary breast cancer.
Topics: Analysis of Variance; Biopsy, Needle; Breast Neoplasms; Female; Humans; Mammography; Physical Examination; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2005 |
Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography.
Topics: Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2005 |
Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Gamma Cameras; Humans; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2005 |
Optimization of the accuracy of retention and washout measurements of 99mTc-Sestamibi from breast tumours using an anthropomorphic phantom.
Topics: Algorithms; Breast Neoplasms; Computer Simulation; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Models, Biological; Phantoms, Imaging; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Technetium Tc 99m Sestamibi | 2005 |
Incidental detection of rounded atelectasis during tc-99m MIBI scintimammography.
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Neoplasm Recurrence, Local; Pulmonary Atelectasis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biopsy, Fine-Needle; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2005 |
Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Topics: Adenocarcinoma; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Breast Neoplasms; Cyclosporins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Metabolic Clearance Rate; Mice; Mice, SCID; Organ Specificity; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Follow-Up Studies; Gamma Cameras; Humans; Middle Aged; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Ultrasonography | 2005 |
Effectiveness of 99mTc-MIBI SPECT-scintimammography at patients with suspicion of breast cancer in relation to mammographic density.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Image Enhancement; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2005 |
[The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Carcinoma, Ductal, Breast; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Female; Glutathione S-Transferase pi; Humans; Immunohistochemistry; Middle Aged; Multidrug Resistance-Associated Proteins; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2005 |
Tc-99m sestamibi uptake in the chest mimicking a malignant lesion of the breast.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; False Positive Reactions; Female; Humans; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2006 |
99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Genetic Therapy; Humans; Metabolic Clearance Rate; Multidrug Resistance-Associated Proteins; Oligodeoxyribonucleotides, Antisense; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; RNA, Messenger; Technetium Tc 99m Sestamibi; Treatment Outcome | 2006 |
Diffuse tracer uptake in scintimammography: not as nonspecific or benign as originally believed?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Image Enhancement; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Diagnostic efficiency of sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; Female; Humans; Male; Mammography; Palpation; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler | 2006 |
Accuracy of ultrasonography and 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Chi-Square Distribution; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2006 |
Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Humans; Hyperplasia; Ki-67 Antigen; Male; Middle Aged; Neoplasm Invasiveness; Precancerous Conditions; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Retrospective Studies; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi | 2006 |
Usefulness of scintimammography with tc-99m MIBI in clinical practice.
Topics: Breast Neoplasms; Calcinosis; Carcinoma, Ductal; False Negative Reactions; Female; Humans; Mammography; Middle Aged; Precancerous Conditions; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2006 |
(99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Humans; Injections, Intravenous; Mammography; Middle Aged; Palpation; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2007 |
Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mammography; Middle Aged; Multidrug Resistance-Associated Proteins; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Technetium Tc 99m Sestamibi | 2006 |
Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Neoadjuvant Therapy; Observer Variation; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2007 |
Clinical importance of (99m)Tc-MIBI mammoscintigraphy in multifocal breast lesions.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Severity of Illness Index; Technetium Tc 99m Sestamibi | 2006 |
[Tentative results of using 99mTC-methoxyisobutyl isonitrile in predicting the effect of preoperative chemotherapy for locally advanced breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2006 |
Role of 99mTc-MIBI scintimammography and X-ray mammography in the diagnosis of locoregional recurrence of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2007 |
Radioguided Intraoperative Margins Evaluation (RIME): preliminary results of a new technique to aid breast cancer resection.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging; Mammography; Mastectomy, Modified Radical; Middle Aged; Neoplasm, Residual; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2007 |
Diagnostic performances of double-phase tc-99m MIBI scintimammography in patients with indeterminate ultrasound findings: visual and quantitative analyses.
Topics: Breast Neoplasms; Female; Humans; Image Enhancement; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2007 |
Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Feasibility Studies; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Mammography; Mastectomy; Middle Aged; Neoplasm Staging; Pilot Projects; Radionuclide Imaging; Sensitivity and Specificity; Software; Technetium Tc 99m Sestamibi | 2007 |
Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Gamma Cameras; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2007 |
99m Tc-sestamibi scintimammography in detection of recurrent breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Positive Reactions; Female; Humans; Image Processing, Computer-Assisted; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Technetium Tc 99m Sestamibi | 2007 |
Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Mastectomy, Radical; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thoracic Wall; Tomography, Emission-Computed, Single-Photon | 2007 |
Primary osteogenic sarcoma of breast detected on Tc-99m MIBI scintigraphy and Tc-99m MDP skeletal scintigraphy.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Rare Diseases; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2008 |
Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care.
Topics: Adult; Benchmarking; Breast Neoplasms; Community Health Centers; Female; Humans; Mass Screening; Neoplasm Staging; Outcome Assessment, Health Care; Radionuclide Imaging; Radiopharmaceuticals; Registries; Retrospective Studies; Risk Adjustment; Survival Analysis; Technetium Tc 99m Sestamibi; United States | 2008 |
Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Gamma Cameras; Humans; Middle Aged; Neoplasm Invasiveness; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2008 |
Technetium-99m sestamibi: an indicator of breast cancer invasiveness.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1994 |
Investigation of abnormal appearing thyroid glands on Tc-99m sestamibi breast scintimammography.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thyroid Gland | 1995 |
The use of technetium-99m sestamibi to indicate breast cancer invasiveness.
Topics: Breast; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Staging; Neovascularization, Pathologic; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1995 |
Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Topics: Axilla; Biopsy; Breast; Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prone Position; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1995 |
Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Topics: Biopsy, Needle; Breast; Breast Neoplasms; Cohort Studies; False Negative Reactions; False Positive Reactions; Female; Humans; Middle Aged; Predictive Value of Tests; Radiography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1995 |
Scintimammography: magic bullet or false promise.
Topics: Breast Neoplasms; Female; Humans; Radiation Dosage; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1995 |
Prone scintimammography in patients with suspicion of carcinoma of the breast.
Topics: Breast Neoplasms; Female; Humans; Mammography; Prone Position; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1995 |
Keeping abreast of time.
Topics: Adult; Breast Neoplasms; Breast Self-Examination; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Magnetic Resonance Imaging; Mammography; Middle Aged; Radioimmunodetection; Receptors, Somatostatin; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Ultrasonography, Mammary | 1995 |
Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Topics: Biopsy, Needle; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; False Negative Reactions; False Positive Reactions; Female; Fibrocystic Breast Disease; Humans; Middle Aged; Predictive Value of Tests; Prone Position; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1995 |
Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Methods; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 1995 |
99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging.
Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibroadenoma; Granulomatous Disease, Chronic; Humans; Mastectomy; Middle Aged; Radionuclide Imaging; Reference Values; Reproducibility of Results; Technetium Tc 99m Sestamibi | 1995 |
Tc-99m MIBI uptake in breast carcinoma and axillary lymph node metastases.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1994 |
Scintimammography: magic bullet or false promise?
Topics: Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1995 |
Exaggerated role of prone technique in breast cancer imaging with technetium-99m methoxyisobutylisonitrile.
Topics: Breast; Breast Neoplasms; Female; Humans; Prone Position; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 1994 |
Case report: technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile imaging of breast cancer and myocardial infarction in the same patient.
Topics: Breast Neoplasms; Contrast Media; Female; Humans; Middle Aged; Myocardial Infarction; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1994 |
Technetium-99m-sestamibi imaging in breast cancer: an alternative to thallium-201 imaging.
Topics: Breast Neoplasms; Humans; Lymphatic Metastasis; Mammography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes | 1994 |
The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.
Topics: Adenocarcinoma; Adult; Aged; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Palpation; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1994 |
Prone scintimammography in patients with suspicion of carcinoma of the breast.
Topics: Adult; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Pilot Projects; Prone Position; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1994 |
Automatic assessment of scintmammographic images using a novelty filter.
Topics: Breast; Breast Neoplasms; Female; Humans; Image Enhancement; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1995 |
Localization of Tc-99m sestamibi and TI-201 in an unsuspected calcified intrathoracic mass.
Topics: Aged; Angina Pectoris; Breast Neoplasms; Calcinosis; Female; Heart; Humans; Lung Diseases; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Tuberculosis, Pulmonary | 1995 |
Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Breast Neoplasms; Drug Resistance, Multiple; Female; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Temperature; Tumor Cells, Cultured; Verapamil | 1996 |
Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Breast Neoplasms, Male; False Negative Reactions; Female; Humans; Lymph Nodes; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Topics: Adenocarcinoma; Breast Neoplasms; Diagnosis, Differential; Evaluation Studies as Topic; Female; Fibroadenoma; Fibrocystic Breast Disease; Humans; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Bilateral signet-ring cell carcinoma of the breast: scintigraphic findings.
Topics: Bone Neoplasms; Breast Neoplasms; Carcinoma, Signet Ring Cell; Female; Humans; Middle Aged; Neoplasms, Multiple Primary; Radionuclide Imaging; Stomach Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 1996 |
Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography.
Topics: Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Neoplasm Staging; Pilot Projects; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 1996 |
Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tumor Cells, Cultured | 1996 |
Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
Topics: Biopsy; Breast; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Organometallic Compounds; Palpation; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.
Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Evaluation Studies as Topic; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Female; Furans; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Time Factors; Tumor Cells, Cultured | 1996 |
Stereotactic coordinates from ECT sinograms for radionuclide-guided breast biopsy.
Topics: Biopsy, Needle; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Phantoms, Imaging; Software; Stereotaxic Techniques; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mammary Neoplasms, Experimental; Organophosphorus Compounds; Organotechnetium Compounds; Rats; Technetium Tc 99m Sestamibi; Time Factors; Tumor Cells, Cultured | 1996 |
New method for breast cancer detection using TC-99m sestamibi scintimammography.
Topics: Adult; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
Sweat glands accumulate Tc-99m MIBI.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Apocrine Glands; Axilla; Breast Neoplasms; Calcium; Female; Humans; Hyperparathyroidism; Hyperplasia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Parathyroid Glands; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1996 |
Recent advances in the diagnosis of breast cancer: scintimammography.
Topics: Breast Neoplasms; Female; Humans; Mass Screening; Predictive Value of Tests; Radioimmunodetection; Technetium Tc 99m Sestamibi | 1996 |
Breast carcinoma fortuitously discovered on myocardial perfusion imaging.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Heart; Humans; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1996 |
Scintimammography in the diagnosis of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
[Comparative study of 201Tl and 99mTc-MIBI in breast tumor].
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1996 |
What is the best technique for patient positioning during breast scintigraphy?
Topics: Breast; Breast Neoplasms; Female; Humans; Posture; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Functional imaging of tumours with 99Tcm-sestamibi pinhole scintigraphy.
Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Follow-Up Studies; Gamma Cameras; Glioblastoma; Humans; Lung Neoplasms; Neoplasms; Radionuclide Imaging; Reproducibility of Results; Skin Neoplasms; Technetium Tc 99m Sestamibi; Urinary Bladder Neoplasms | 1996 |
Scintimammography--a new tool for breast cancer diagnosis.
Topics: Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1996 |
Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Accumulation of Tc-99m MIBI in breast lymphoma: comparison with Ga-67 citrate.
Topics: Breast Neoplasms; Citrates; Evaluation Studies as Topic; Female; Gallium; Gallium Radioisotopes; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Breast cancer staging using technetium-99m sestamibi and indium-111 pentetreotide single-photon emission tomography.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Medullary; Evaluation Studies as Topic; Female; Humans; Indium Radioisotopes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Somatostatin; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Immunoenzyme Techniques; Middle Aged; Phenotype; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
99mTC-MIBI uptake in metastatic renal cell carcinoma.
Topics: Breast Neoplasms; Carcinoma, Renal Cell; Female; Humans; Lung Neoplasms; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Topics: Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mammography; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Phyllodes Tumor; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Solitary breast metastasis as the first sign of a squamous cell carcinoma of the cervix: imaging findings.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Mammography; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary; Uterine Cervical Neoplasms | 1997 |
Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Female; Gamma Cameras; Glucaric Acid; Humans; Indium Radioisotopes; Metabolic Clearance Rate; Mice; Mice, SCID; Organotechnetium Compounds; Radioimmunodetection; Scintillation Counting; Technetium Tc 99m Pentetate; Technetium Tc 99m Sestamibi; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Contrast Media; Female; Fibroadenoma; Humans; Mammography; Middle Aged; Phyllodes Tumor; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 1996 |
Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy.
Topics: Breast Neoplasms; Coronary Disease; Echocardiography; Electrocardiography; Exercise Test; Female; Heart; Humans; Middle Aged; Prospective Studies; Radiation Injuries; Radionuclide Imaging; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Medullary; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Female; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
Wash-out kinetics of 99mTc-MIBI and the scintigraphic determination of PGP expression.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
The initial Australian experience of technetium-99M sestamibi scintimammography: a complementary test in the management of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast Neoplasms; Female; Follow-Up Studies; Humans; Mammography; Middle Aged; Neoplasm Staging; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Utility and reproducibility of semiquantitative analysis of sestamibi breast images.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Breast Neoplasms, Male; Female; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Observer Variation; Prone Position; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thorax | 1997 |
Tc-99m sestamibi and Tc-99m HMDP uptake in a malignant phyllodes tumor of the breast.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 1997 |
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Topics: Axilla; Breast Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
The effect of chemotherapy on the uptake of technetium-99m sestamibi in breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Genes, MDR; Humans; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 1997 |
The diagnostic value of planar and SPET scintimammography in different age groups.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Immunoenzyme Techniques; Neoplasm Proteins; Radionuclide Imaging; Risk Factors; Technetium Tc 99m Sestamibi | 1997 |
Tc-99m sestamibi scintimammography in the evaluation of response of breast carcinoma to chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Evaluation Studies as Topic; Female; Fluorouracil; Follow-Up Studies; Humans; Mastectomy, Modified Radical; Neoplasm Staging; Premenopause; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Treatment Outcome | 1997 |
Tc-99m MIBI bone marrow uptake in bone marrow fibrosis secondary to metastatic breast carcinoma.
Topics: Biopsy; Bone Marrow; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Myocardial Ischemia; Primary Myelofibrosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 1997 |
Three patients with bilateral breast tumors examined by technetium-99m-sestamibi scintimammography.
Topics: Adolescent; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Neoplasms, Multiple Primary; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography | 1997 |
Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Topics: Breast; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Topics: Breast; Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Topics: Breast Neoplasms; Female; Humans; Magnetic Resonance Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Detection of axillary lymph node metastasis of breast carcinoma with technetium-99m sestamibi scintimammography.
Topics: Adult; Aged; Axilla; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Evaluation Studies as Topic; Female; Forecasting; Humans; Injections, Intravenous; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Modified Radical; Mastectomy, Segmental; Middle Aged; Nuclear Medicine; Observer Variation; Predictive Value of Tests; Prone Position; Radiology; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi | 1997 |
Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms.
Topics: Breast Diseases; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
99Tcm-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement.
Topics: Adult; Aged; Breast Neoplasms; Case-Control Studies; False Negative Reactions; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Decision analysis: MIBI imaging of nonpalpable breast abnormalities.
Topics: Biopsy; Breast; Breast Neoplasms; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Stereotaxic Techniques; Technetium Tc 99m Sestamibi | 1997 |
A perspective on decision analysis modeling as it relates to sestamibi imaging of nonpalpable breast abnormalities.
Topics: Biopsy; Breast Neoplasms; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Stereoisomerism; Technetium Tc 99m Sestamibi | 1997 |
Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
Breast tumour imaging using incomplete circular orbit pinhole SPET: a phantom study.
Topics: Breast Neoplasms; Equipment Design; Female; Humans; Mammography; Models, Anatomic; Phantoms, Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
[Scintigraphy does no show small nodules of the breast].
Topics: Biopsy, Needle; Breast; Breast Neoplasms; Female; Humans; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1997 |
Characterization of P-glycoprotein transport and inhibition in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Cyclosporins; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, Nude; Neoplasms, Experimental; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Topics: Breast Neoplasms; Breast Neoplasms, Male; Female; Humans; Male; Middle Aged; Palpation; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
[Breast carcinoma and the axillary lymph node status: the use of 99mTc-sestamibi scintimammography for the diagnosis and preoperative staging. Preliminary results].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast; Breast Neoplasms; Carcinoma; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1997 |
99mTc MIBI prone scintimammography in patients with suspicious breast cancer: relationship with mammography and tumor size.
Topics: Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Female; Humans; Lymph Nodes; Mammography; Middle Aged; Probability; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography.
Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.
Topics: Breast; Breast Diseases; Breast Neoplasms; Female; Humans; Neovascularization, Pathologic; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
Topics: Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging.
Topics: Algorithms; Breast Diseases; Breast Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
[Value of 99mtechnetium-MIBI scintigraphy in breast diagnosis].
Topics: Adult; Aged; Aged, 80 and over; Breast Diseases; Breast Neoplasms; Carcinoma in Situ; Diagnosis, Differential; Female; Humans; Lymphatic Metastasis; Middle Aged; Precancerous Conditions; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Role of 99mTc-Sestamibi scintimammography by SPEM camera in the management of breast cancer in the elderly.
Topics: Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Humans; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
[Gammography using Tc 99m MIBI in patients with suspected breast cancer. Proposed diagnostic protocol].
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Membrane; Female; Furans; Humans; Kinetics; Male; Mitochondria; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured | 1998 |
Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Evaluation Studies as Topic; False Negative Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Observer Variation; Palpation; Predictive Value of Tests; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi | 1998 |
Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Female; Humans; Immunohistochemistry; Middle Aged; Neoplasm Proteins; Prospective Studies; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Can scintimammography reduce "unnecessary" biopsies?
Topics: Biopsy; Breast; Breast Neoplasms; Case-Control Studies; Evaluation Studies as Topic; Female; Humans; Mammography; Middle Aged; Palpation; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
The usefulness of Tc-99m sestamibi scintimammography in the diagnosis of squamous cell carcinoma of the breast.
Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1998 |
Tetrofosmin thyroid scintigraphy.
Topics: Antineoplastic Agents; Breast Neoplasms; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Gland; Tomography, Emission-Computed, Single-Photon | 1998 |
Chemotherapy and uptake of technetium-99m sestamibi in breast cancer: reply.
Topics: Breast Neoplasms; Humans; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1998 |
Detection of recurrent malignant melanoma with 99mTc-MIBI scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Digestive System Neoplasms; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radioimmunodetection; Sensitivity and Specificity; Skin Neoplasms; Technetium Tc 99m Sestamibi | 1998 |
99mTc-sesta-(2-methoxy-isobutyl-isonitrile) uptake by pancreatic islets, parotid cells, and mammary carcinoma cells.
Topics: Animals; Breast Neoplasms; Carcinoma; Female; Humans; Islets of Langerhans; Parotid Gland; Rats; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1998 |
Uptake of cationic technetium complexes in cultured human carcinoma cells and human xenografts.
Topics: Animals; Breast Neoplasms; Cations; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Nitriles; Subrenal Capsule Assay; Technetium Compounds; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured | 1998 |
Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer.
Topics: Bias; Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1998 |
[Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging].
Topics: Adenoma; Breast Neoplasms; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography | 1997 |
[Multifocal breast neoplasm with bone involvement].
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Female; Femoral Neoplasms; Humans; Humerus; Lymphatic Metastasis; Radionuclide Imaging; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 1998 |
99mTc-MIBI scintimammography using a dedicated nuclear mammograph.
Topics: Adult; Aged; Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
Preoperative evaluation of the chemosensitivity of breast cancer by means of double phase 99mTc-MIBI scintimammography.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Middle Aged; Preoperative Care; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 1999 |
[Initial experiences with radionuclide mammography at the Cottbus Carl-Thiem Clinic].
Topics: Adult; Biopsy; Breast; Breast Neoplasms; Female; Humans; Neoplasm Staging; Precancerous Conditions; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1998 |
Internal mammary nodal metastases from breast cancer detected by scintimammography.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymphatic Metastasis; Mediastinal Neoplasms; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 1999 |
Comparison of planar and SPECT scintimammography with 99mTc-sestamibi in the diagnosis of breast carcinoma.
Topics: Breast; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Middle Aged; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 1999 |
Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.
Topics: Adult; Aged; Breast; Breast Neoplasms; Electric Impedance; Electrodiagnosis; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Isoquinolines; Mammary Neoplasms, Animal; Mice; Mice, SCID; Neoplasm Transplantation; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tetrahydroisoquinolines; Transplantation, Heterologous | 1999 |
Tc-99m sestamibi exam finds niche in breast Dx.
Topics: Breast; Breast Neoplasms; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1997 |
[Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization].
Topics: Breast Neoplasms; Cost-Benefit Analysis; Female; Germany; Humans; Medical Oncology; Nuclear Medicine; Switzerland; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; United States | 1999 |
Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and P-glycoprotein expression in patients with untreated breast cancer.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Breast; Breast Neoplasms; Breast Neoplasms, Male; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1999 |
99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Axilla; Biopsy; Biopsy, Needle; Breast Diseases; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Carcinoma, Papillary; Female; Fibroadenoma; Follow-Up Studies; Humans; Mammography; Mastectomy; Middle Aged; Neoplasm Invasiveness; Observer Variation; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1999 |
Procedure guideline for breast scintigraphy. Society of Nuclear Medicine.
Topics: Adult; Breast; Breast Neoplasms; Female; Humans; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Scintimammography (SMM) in breast cancer patients.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thailand; Thallium Radioisotopes | 1999 |
Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Humans; Magnetic Resonance Imaging; Mammography; Middle Aged; Neoplasms, Multiple Primary; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
99Tcm-MIBI scintimammography for the detection of breast malignancies: the contribution of the count ratio to specificity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Evaluation of planar scintimammography with 99mTc-MIBI in the detection of axillary lymph node metastases of breast carcinoma.
Topics: Axilla; Breast Neoplasms; Carcinoma in Situ; Diagnosis, Differential; Diagnostic Errors; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Is scintimammography really the most valuable preoperative assessment tool?
Topics: Breast Neoplasms; Female; Humans; Mammography; Predictive Value of Tests; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Breast cancer detection with 99m-Tc-sestamibi scintigraphy, mammography, and fine-needle aspiration cytology: comparative study in 64 surgically treated patients.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Women's health issues and nuclear medicine, part II: women and breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Mammography; Mass Screening; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary; Women's Health | 1999 |
The importance of patient positioning in the detection of axillary lymphatic involvement with Tc-99m sestamibi scintimammography.
Topics: Adult; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymphatic Metastasis; Posture; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 1999 |
Tc-99m sestamibi scintimammography in the mammographically dense breast.
Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibrosis; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
[Role of 99mTC-Sestamibi in the diagnosis of breast cancer. Report on 100 cases].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
99mTc-MIBI scan in mammary Pagets disease: a case report.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Nipples; Paget's Disease, Mammary; Radionuclide Imaging; Skin; Technetium Tc 99m Sestamibi | 1999 |
Occult breast cancer detection with technetium-99m-sestamibi: a case report.
Topics: Aged; Bone Neoplasms; Breast Neoplasms; Carcinoma; Female; Humans; Lymphatic Metastasis; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 1999 |
Breast parenchymal activity on scintimammography: comparison between bone-seeking agents and 99mTc-sestamibi.
Topics: Adult; Aged; Bone Neoplasms; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 1999 |
Chest wall recurrence of breast cancer detected by scintimammography.
Topics: Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thoracic Neoplasms; Time Factors | 2000 |
99Tcm-MIBI scintimammography in 300 consecutive patients: factors that may affect accuracy.
Topics: Adult; Aged; Breast Neoplasms; False Negative Reactions; False Positive Reactions; Female; Humans; Mammography; Middle Aged; Neovascularization, Pathologic; Postmenopause; Premenopause; Proliferating Cell Nuclear Antigen; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reproducibility of Results; Technetium Tc 99m Sestamibi | 1999 |
Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Topics: Breast; Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2000 |
The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carbon Radioisotopes; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Humans; Mammary Neoplasms, Experimental; Mice; Models, Biological; Radiopharmaceuticals; Sarcoma, Experimental; Sucrose; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 2000 |
A comparison of 99Tcm-MDP and 99Tcm-MIBI in the detection of breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Middle Aged; Radiography; Radiopharmaceuticals; Supine Position; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2000 |
The comparison of dual phase Tc-99m MIBI and tc-99m MDP scintimammography in the evaluation of breast masses: preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2000 |
Positive Tc-99m MIBI breast study related to a psoriatic lesion.
Topics: Breast Diseases; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Middle Aged; Nipples; Paget's Disease, Mammary; Psoriasis; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2000 |
Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Calcinosis; Conjunctival Neoplasms; Equipment Design; Eye Diseases; Eye Neoplasms; False Positive Reactions; Female; Gamma Cameras; Humans; Image Processing, Computer-Assisted; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nevus; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Uveitis | 2000 |
[++Scintimammography: a new imaging technique for diagnosis and follow-up of breast cancer].
Topics: Adenocarcinoma, Mucinous; Adenofibroma; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Feasibility Studies; Female; Follow-Up Studies; Humans; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sclerosis; Technetium Tc 99m Sestamibi | 2000 |
Scintimammographic findings of in situ ductal breast carcinoma in a double-phase study with Tc-99m(V) DMSA and Tc-99m MIBI value of Tc-99m(V) DMSA.
Topics: Breast; Breast Neoplasms; Calcinosis; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2000 |
Tc-99m sestamibi and In-111 DTPA octreotide uptake in breast carcinoma with neurendocrine differentiation.
Topics: Aged; Breast Neoplasms; Carcinoma; Carcinoma, Neuroendocrine; Diagnosis, Differential; Female; Humans; Indium Radioisotopes; Octreotide; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Terbium | 2000 |
The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.
Topics: Adult; Aged; Biopsy, Needle; Breast Neoplasms; Evaluation Studies as Topic; Female; Humans; Mammography; Middle Aged; Palpation; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
Topics: Adult; Aged; Biopsy, Needle; Breast; Breast Neoplasms; Cost-Benefit Analysis; Female; Humans; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Mammary | 2000 |
Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
Topics: alpha-Fetoproteins; Animals; Breast Neoplasms; Carcinoma, Hepatocellular; Female; Humans; Mice; Mice, Inbred ICR; Mice, SCID; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Recombinant Proteins; Technetium; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |
Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Topics: Adult; Breast; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1999 |
Scintimammography with 11beta-methoxy-(17alpha,20Z)-[123I]iodovinylestrad iol: a complementary role to 99mTc-methoxyisobutyl isonitrile in the characterization of breast tumors.
Topics: Adult; Aged; Biological Transport; Breast Neoplasms; Estradiol; Female; Gamma Cameras; Humans; Image Interpretation, Computer-Assisted; Iodine Radioisotopes; Middle Aged; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Estrogen; Technetium Tc 99m Sestamibi | 2000 |
Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies.
Topics: Biopsy; Breast Neoplasms; Cost Savings; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Decision Trees; Disease Progression; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Life Expectancy; Mammography; Mass Screening; Medicare; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; United States; Unnecessary Procedures | 2000 |
Scintigraphic evolution of a breast cancer with Tc-99m MIBI scintimammography.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Female; Humans; Lymph Nodes; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast; Breast Neoplasms; Cell Line; Female; Humans; Kinetics; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2000 |
The role of scintimammography with 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fibrocystic Breast Disease; Humans; Mammography; Middle Aged; Physical Examination; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
Visualization of the right atrial appendage during sestamibi scintigraphy.
Topics: Angina Pectoris; Breast Neoplasms; Diagnosis, Differential; Female; Heart Atria; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
[Scintigraphy with 99mTc-MIBI in the diagnosis of axillary lymph node invasion of breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
[Usefulness of quantification and visual analysis of the uptake of (99m)Tc-MIBI in the diagnosis of mammary lesions].
Topics: Algorithms; Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Fibroadenoma; Humans; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Technetium Tc 99m Sestamibi | 2000 |
[Usefulness of the quantification of (99M)Tc-MIBI uptake in breast neoplasms in the preoperative assessment of tumor aggressiveness].
Topics: Breast Neoplasms; Female; Humans; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2000 |
[99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Topics: Adult; Age Factors; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
The use of external radioactive markers in scintimammography.
Topics: Adult; Breast; Breast Neoplasms; Cobalt Radioisotopes; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Imaging tumors in humans with Tc-99m-VIP.
Topics: Adenocarcinoma; Adult; Amino Acid Sequence; Autoradiography; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasms; Organotechnetium Compounds; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Technetium Tc 99m Sestamibi; Vasoactive Intestinal Peptide | 2000 |
Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
P-Glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Resistance, Multiple; Female; Humans; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi | 2001 |
Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Breast Neoplasms; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplasms; Organophosphorus Compounds; Organotechnetium Compounds; Patient Selection; Radionuclide Imaging; Radiopharmaceuticals; Substrate Specificity; Technetium Tc 99m Sestamibi | 2001 |
[The role of MIBI scintigraphy in the early detection of breast cancer].
Topics: Adult; Breast Neoplasms; Diagnosis, Differential; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Breast cancer cellular proliferation indexes and 99mTc-sesta Mibi capture: what correlation?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cell Division; Female; Humans; Middle Aged; Mitotic Index; Neoplasm Staging; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Importance of the choice of the collimator for the detection of small lesions in scintimammography: a phantom study.
Topics: Breast Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Mammography; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in suspected recurrent breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Diagnosis, Differential; False Negative Reactions; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
Statin induced myopathy does not show up in MIBI scintigraphy.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Breast Neoplasms; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Indoles; Lovastatin; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Pain; Pravastatin; Pyridines; Pyrroles; Radionuclide Imaging; Radiopharmaceuticals; Simvastatin; Technetium Tc 99m Sestamibi | 2001 |
Verapamil decreases accumulation of 99Tcm-MIBI and 99Tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Calcium Channel Blockers; Cell Line; Cell Survival; Female; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 2001 |
Scintimammography with 99mTc-sestamibi as a complementary diagnostic technique.
Topics: Breast; Breast Neoplasms; Female; Humans; Mammography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2001 |
Value of 99mTc-MIBI scintimammography in women with impalpable breast lesions seen on mammography.
Topics: Aged; Breast Neoplasms; Female; Humans; Logistic Models; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Diagnostic value of 99mTc MIBI scintimammography in patients with breast lesions.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Diagnosis, Differential; False Positive Reactions; Female; Fibrocystic Breast Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Could 99mTc-MIBI be used to visualize the apoptotic MCF7 human breast cancer cells?
Topics: Apoptosis; Breast Neoplasms; Cell Division; DNA; Female; Humans; Phenylacetates; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2001 |
New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives.
Topics: Breast Neoplasms; Chemistry, Pharmaceutical; Cyclopentanes; Estrogens; Half-Life; Molecular Structure; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Peptides; Proteins; Radioisotopes; Radiopharmaceuticals; Rhenium; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Technetium Tc 99m Sestamibi | 2001 |
Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Topics: Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Bridged-Ring Compounds; Carcinoma; Female; Genes, MDR; Humans; Middle Aged; Polymerase Chain Reaction; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; RNA, Messenger; Taxoids; Technetium Tc 99m Sestamibi; Treatment Outcome | 2001 |
99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Topics: Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2001 |
Impact of patient positioning in scintimammography.
Topics: Breast; Breast Neoplasms; Female; Humans; Posture; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2001 |
Scintimammography: better detection of small-sized lesions with tomoscintigraphic than planar images, a phantom study.
Topics: Breast; Breast Neoplasms; Female; Humans; Phantoms, Imaging; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 2001 |
[To the Editor: Regarding the role of MIBI-scintigraphy in the early diagnosis of breast cancer].
Topics: Biopsy, Needle; Breast Neoplasms; Female; Humans; Mammography; Palpation; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors | 2001 |
Incidental detection of a single brain metastasis from breast carcinoma during Tc-99m MIBI scintimammography.
Topics: Adult; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
Impact of patient positioning in scintimammography.
Topics: Breast; Breast Neoplasms; Female; Humans; Lymph Nodes; Prone Position; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2001 |
The role of 99m Tc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler, Color | 2001 |
Comparison of dynamic MR imaging of the breast and sestamibi scintimammography for evaluation of indeterminate mammographic lesions.
Topics: Adult; Aged; Breast Neoplasms; Humans; Magnetic Resonance Imaging; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Topics: Adult; Breast Diseases; Breast Neoplasms; Calcinosis; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Humans; Mammography; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography | 2001 |
Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer.
Topics: Breast; Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Predictive Value of Tests; Premenopause; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2001 |
The clinical utility of Tc-99m sestamibi scintimammography in detecting multicentric breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2001 |
99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2000 |
Sestamibi scanning of breast cancer.
Topics: Biopsy; Breast; Breast Neoplasms; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
[Correlation between accumulation of (99m)Tc-MIBI in breast cancer or benign lesion, cell proliferation and angiogenesis].
Topics: Adult; Breast; Breast Neoplasms; Cell Division; Female; Humans; Immunohistochemistry; Middle Aged; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Radionuclide Imaging; Regression Analysis; Technetium Tc 99m Sestamibi | 1998 |
[The value of 99mTc-MIBI image axillary lymph node in selecting operative method for breast cancer].
Topics: Adult; Aged; Axilla; Breast Neoplasms; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 1999 |
Breast tumor localization using sestamibi.
Topics: Breast Neoplasms; Female; Humans; Mammography; Middle Aged; Palpation; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
What can we expect from MDR breast cancer imaging with sestamibi?
Topics: ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily B; Breast; Breast Neoplasms; Drug Resistance, Multiple; Female; Humans; Immunohistochemistry; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Selective Estrogen Receptor Modulators; Technetium Tc 99m Sestamibi; Toremifene | 2002 |
Tc-99m MIBI filling pattern in a photopenic area of a Tc-99m MDP scan in a patient with metastatic bone involvement of breast carcinoma.
Topics: Aged; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Skull Neoplasms; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi | 2002 |
Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.
Topics: Adult; Aged; Antigens, CD; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Resistance, Neoplasm; Female; Humans; Mammography; Membrane Glycoproteins; Middle Aged; Phenotype; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tetraspanin 29 | 2002 |
Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Mammography; Neoplasm Staging; Neoplasms, Ductal, Lobular, and Medullary; Phyllodes Tumor; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Sestamibi | 2002 |
Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast.
Topics: Adult; Aged; Breast; Breast Neoplasms; Carcinoma; Diagnosis, Differential; False Positive Reactions; Female; Humans; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Ultrasonography | 2002 |
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Humans; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi | 2002 |
Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent "99mTc MIbI".
Topics: Adult; Aged; Axilla; Breast Neoplasms; Coloring Agents; Female; Humans; Injections, Intralesional; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sentinel Lymph Node Biopsy; Technetium Tc 99m Sestamibi | 2002 |
High-resolution scintimammography: a pilot study.
Topics: Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Mammography; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2002 |
Invited commentary: one step forward.
Topics: Breast; Breast Neoplasms; Female; Gamma Cameras; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2002 |
Concordant uptake of Tc-99m sestamibi and Tl-201 in unsuspected breast tumor.
Topics: Aged; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Exercise Test; Female; Humans; Myocardial Ischemia; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 1992 |